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SUMMARY 
 
The prevalence of type 2 diabetes mellitus (T2DM) is rising at an alarming 
rate, making DM a major health problem worldwide. A multifaceted approach is 
taken in the battle against T2DM, with prevention being an important cornerstone. 
Other important components of T2DM management include DM education and 
measurement of patient-reported outcomes (PROs). However, currently, the impact of 
these approaches among Asian populations is relatively unexplored. The evaluation of 
their impact on T2DM management is of particular importance in view of the much 
less abundant availability of healthcare resources in Asia. 
 
 Based on the afore-mentioned reasons, this thesis therefore focused on various 
approaches, especially health outcomes assessment, in T2DM management in Asia. In 
our studies, Thailand was chosen as an illustrating example based on the following 
considerations. First, T2DM is one of the most prevalent chronic diseases there, and 
Thailand is among the top ten countries in Asia with the highest number of adults 
with T2DM. Second, there are limited numbers of published studies concerning this 
topic in the Thai population. Third, Thailand is a country with a mix of rural and 
cosmopolitan areas which may allow further generalization of the results to other 
countries with similar socioeconomic compositions.  
 
This thesis is broadly organized into two sections. We started by evaluating 
DM knowledge among the general population in central Thailand and found this to be 
generally fair indicating the existence of a foundation for further improvement. 
Interestingly, we found that the residents in other provinces outperformed those in the 
  viii 
capital demonstrating that easier access to health information may not translate into 
better health knowledge. Further, we identified differing factors associated with DM 
knowledge between the two groups highlighting the need for different emphasis in 
future health promotion and education.  
  
This was followed by our cross-culturally adapting and validating a Thai 
version of the Audit of Diabetes-Dependent Quality of life (ADDQoL-19), a DM-
specific QoL instrument, among DM patients in Thailand and found it to be a 
promising tool. We also evaluated the psychometric properties of a Thai version of 
the Diabetes Treatment Satisfaction Questionnaire status version (DTSQs), a DM-
specific treatment satisfaction instrument, and the results suggested that further 
improvements may be required for this instrument to be used in routine clinical 
setting. Further, we assessed health status, quality of life (QoL) and treatment 
satisfaction of DM patients in Thailand. We found that DM had little effect on the 
patients‟ perceived health status but major negative impact on their QoL while their 
treatment satisfaction was high. We also found that the factors associated with these 
PROs were not identical. In addition, we evaluated the association between 
polypharmacy and QoL and found no significant association. Overall, these results 
would provide some insights to healthcare providers in designing more holistic 
intervention strategies for DM management. 
 
In conclusion, our studies would at least fill a knowledge gap in DM 
management in Thailand (if not beyond) and would serve as a foundation for further 
studies in more cost-effective approach in managing DM. 
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1. INTRODUCTION 
1.1. The global burden of type 2 diabetes mellitus (T2DM) 
T2DM, accounting for 90 to 95% of all DM cases,
(1, 2)
 is characterized by the 
presence of insulin resistance or relative insulin deficiency. It often has a familial or 
genetic predisposition, and is largely associated with advancing age, sedentary 
lifestyle and obesity.
(1-3)
 Due to its insidious and slow onset, T2DM is frequently not 
diagnosed until symptoms of its complications appear.  
 
 T2DM places a tremendous burden on both patients and healthcare systems. 
According to the World Health Organization (WHO), DM accounted for 
approximately 987,000 deaths or 1.7% of the total world mortality in 2002,
(4)
 and its 
mortality rate is projected to increase from 1.9% in 2004 to 3.3% in 2030.
(5)
 The 
International Diabetes Federation (IDF) estimated that the total number of deaths 
from DM in the age group between 20 to 79 years would be nearly four millions, 
accounting for 6.8% of the global mortality for all age groups in 2010.
(2)
 DM was 
ranked as the fourth leading cause of death by disease worldwide and in Thailand in 
2005.
(6, 7) 
However, the real impact of DM is likely to be higher as DM is often under-
reported as the principal cause of death.
(2) 
 
Additionally, T2DM is one of the principal causes of premature morbidity in 
most countries.
(2)
 Approximately 20-40% of T2DM patients have retinopathy at the 
time of diagnosis,
(8)
 and 2% could become blind after having T2DM for fifteen 
years.
(9)
 Compared with the general population, patients with T2DM have two- to 
four-fold increased risk of cardiovascular disease (CVD), which accounts for 75% of 
all deaths among T2DM patients.
(10) 
Hypertension is also approximately twice as 
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common in T2DM patients as individuals without DM.
(9, 10) 
DM nephropathy occurs 
in 15 to 60% of patients with T2DM 
(11)
 and many patients have to undergo dialysis 
and/or kidney transplant eventually.
(9)
 Furthermore, T2DM patients have an increased 
risk of developing DM neuropathy, which is the most common cause of non-




Besides increasing mortality and morbidity, T2DM could profoundly worsen 
quality of life (QoL) of both patients themselves and their caregivers.
(12) 
T2DM 
patients are prone to experience a variety of psychosocial problems, including guilt, 
frustration, anxiety, depression and social withdrawal,
(12-14)
 and possibly encounter 
restricted range of employment.
(13)
 For caregivers, some even have to quit their jobs 
and have their lifestyle changed to provide care for the patients, not to mention that 
they are also likely to suffer from psychosocial impacts of T2DM as well. 
 
 
In addition to substantial physical, mental and social well-being burden, 
T2DM places heavy economic burden on both the individuals and healthcare 
systems.
(1, 15)
 Global healthcare expenditure attributable to DM and its complications 
is estimated to be at least 376 billion U.S. Dollar (USD), accounting for 12% of total 
health expenditure in 2010, and the amount is projected to be over 490 billion USD in 
2030.
(2, 5)
 Even so, this mentioned expenditure is likely to be an underestimate as 
intangible costs such as pain and suffering, reduction in QoL, as well as the costs of 
undiagnosed cases of T2DM were excluded.
(16) 
 
Likewise, the economic burden of DM in Asia is also enormous due to its high 
incidence and prevalence.
(9)
 In Thailand, the healthcare expenditure for DM is 
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estimated at approximately 510 million USD, accounting for 11% of total health 
expenditure in 2010, and is projected to be at least 720 million USD in 2030.
(17)
 A 
point of concern is that the prevalence of T2DM is increasing in people aged 20 to 64 
years, which is considered the economically-productive age group. Therefore, 
enormous healthcare expenditure and also the loss of productivity due to T2DM and 





1.2. The role of disease management in containing the T2DM epidemic  
Due to the need to improve quality of healthcare as well as the growing 
prevalence of chronic diseases which is inevitably accompanied by greatly increased 
healthcare expenditures, disease management has been increasingly accepted to 
represent a dramatic shift in healthcare delivery philosophy in the new millennium. 
Generally speaking, disease management could be defined as “an organized, 
proactive, multi-component, patient-centered approach to healthcare delivery that 
involves all members of a defined population who have a specific disease entity or a 
subpopulation with specific risk factors.”(18) Indeed, being a common and costly 
chronic disease that is often complex and difficult to manage, T2DM is an ideal 
candidate for applying the concept of disease management.
(18) 
The main goal of 
T2DM management is to optimize the patients‟ clinical, humanistic and economic 
outcomes while reducing the overall healthcare costs.
(19, 20)
 However, for an effective 
T2DM management program, patients themselves as well as other stakeholders (i.e. 
healthcare practitioners/providers, policy makers, payers, purchasers and product 
producers) have to be involved in the care process.
(19, 21)  
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1.3. T2DM management in Thailand: the state of affairs 
In order to improve the quality and standards of the national healthcare system, 
the National Health Security Act was enacted in Thailand in 2002.
(22)
 Realizing the 
growing burden of T2DM that would have potentially overwhelmed the country‟s 
healthcare system, the National Health Security Office (NHSO) places T2DM as one 
of the important diseases to focus its attention.
(23)
 Since then, many national 
campaigns have been launched to deal with this potential growing epidemic. These 
campaigns include promoting health screening of general population, especially high-
risk groups, promoting healthy, active lifestyle and providing DM education to both 
patients and the public.
(23)
 In addition, as there is an obvious and worrying trend of 
downward age shift with T2DM being increasingly diagnosed among younger Thais, 
resulting from an increasing trend of childhood obesity, campaigns to prevent obesity 
among Thai children have also been initiated.  
 
However, according to the country‟s Third National Health Examination 
Survey in 2004, T2DM continues to be a major public health problem with the 
prevalence rates of DM and impaired fasting glucose (IFG) in Thai adults aged >15 
years stood at 6.7% and 12.5%, respectively.
(24) 
Furthermore, the survey revealed that 
more than half of those identified with T2DM had not been previously diagnosed. The 
diagnosis and appropriate management level of DM comorbidities such as 
hypertension and dyslipidemia among individuals with DM were also found to be 
low.
(24) 
 These findings indicate that stronger efforts are needed for the prevention and 
control of T2DM among Thai populations.  
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Incidentally, an improvement in medical care for T2DM patients in Thailand 
has been gradually made, with the Chronic Care Model, developed by Wagner EH et 
al. in the U.S., being applied to T2DM care system in some tertiary hospitals with full 
complement of clinical support services.
(25)
 However, even though this 
implementation would potentially contribute to a more effective management of 
T2DM in Thailand, it requires much financial and human resources to move forward; 
and this could be a major obstacle for the country. Therefore, management of T2DM 
in Thailand is challenging and still requires much more effort in its improvement.  
 
1.4. Prevention: the cornerstone of T2DM management  
Accepting that the T2DM epidemic is currently a major health concern 
worldwide, prevention and control of T2DM including its complications is logically 
one of the priorities for T2DM management.
(2)
 Theoretically speaking, disease 
prevention for T2DM could be implemented at three levels: (a) primary prevention in 
general population, particularly in high risk individuals, to reduce the incidence of 
T2DM; (b) secondary prevention in undiagnosed people for an early detection of the 
disease and prevention of DM complications; and (c) tertiary prevention in 
symptomatic patients to prevent the progression of the disease and development of its 
complications. From the perspective of public health, if implemented successfully, 
primary prevention is likely to be the most cost-effective method of reducing the 
incidence and prevalence of T2DM.
(19, 26)  
 
1.4.1. Knowledge of DM and its role in T2DM prevention  
For primary prevention, health education and promotion are important steps 
towards T2DM prevention and control, and they are beneficial not only to the patients 
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but also the general population.
(27-29)
 Primary prevention of T2DM by raising public 
awareness of the disease should be considered as a priority due to the insidious and 
slow onset of T2DM. Many people are unaware that they have developed the disease 
until symptoms of its complications appear. Adequate knowledge of T2DM 
symptoms is therefore important for ensuring early diagnosis and prompt treatment to 
reduce the risk of developing major DM complications.
(30)
 Furthermore, if the public 
is well aware of the detrimental impact of T2DM and the fact that T2DM is largely 
associated with sedentary lifestyle and obesity, they are possibly keener to adopt a 
healthy lifestyle to delay or reduce the risk of developing this devastating disease. 
Finally, with adequate knowledge on T2DM management and monitoring, healthy 
populations can play an important role in guiding their relatives who have T2DM to 
comply with the required treatment and self-monitoring. As highlighted by Gunay et 
al.,
 
raising public awareness of DM would contribute to reduced incidence and 
prevalence of the disease as well as improved overall health behavior of the 
society.
(31)
 However, as culture and tradition can influence the formation of 
perception and knowledge among populations, the level of knowledge on DM among 
different populations is likely to be different.
(31)
 Hence, instead of assuming the 
results from published studies to be applicable, it is essential to assess the level of DM 
knowledge and ascertain the knowledge gap about DM among the targeted 
population. This information would assist healthcare providers/educators in 
formulating an effective health education and promotion program in a given country.  
 
1.4.2. Factors associated with knowledge of DM 
Similar to the level of DM knowledge, a number of previous studies 
conducted in patients with DM and/or a healthy population illustrated that factors 
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associated with knowledge of DM among populations could vary from country to 
country. According to the findings from those studies, knowledge on DM could be 
affected by various sociodemographic and clinical variables of the study population. 
These variables included gender,
(32-36) 
age,
(29, 33, 34, 37-46) 
ethnicity,
(32, 34, 41, 42, 44)
 
education level,






having family history of DM or having friends who had DM,
(29, 31, 32, 39, 41, 47) 
having DM themselves,
(28, 31, 41, 46) 
type of DM (type 1 or type 2),
(29, 32, 35)
 duration of 
diagnosed DM 
(28, 33, 34, 38, 43)
 and type of treatment regimen (lifestyle modification, 
oral hypoglycemic agents and/or insulin).
(29, 33, 35, 42, 43)
  
 
Despite inconsistent results among studies, education level was found to be the 
main determinant of DM knowledge in most studies. However, again, there were 
conflicting conclusions as to the impact of some factors. For example, while many 
studies found a negative relation between age and knowledge of DM,
(29, 33, 34, 37-43)
 
several studies found lower level of DM knowledge in younger people,
(44-46)
 and a 
number of recent studies revealed no association between the two variables.
(28, 31, 47)
 
Likewise, while males were found to have better knowledge of DM in a number of 
studies,
(32, 33, 35, 36) 
contradicting result was obtained from a study in the U.S.
(34)
 
Adding further to the confusion, several studies found no association between gender 
and knowledge of DM.
(31, 39, 40, 44, 46, 47)
 This highlights that this is an area that would 
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1.5. Measuring the outcomes of T2DM management: the role of patient-
reported outcomes (PROs) 
1.5.1. QoL as an outcome measure of T2DM management  
QoL has become a topic of interest in healthcare research and practice since 
the WHO defined health as “a state of complete physical, mental and social well-
being and not merely the absence of disease or infirmity” in 1948.(48) While its 
universally agreed definition still cannot be achieved, with definitions proposed 
ranging from narrow to broad ones, QoL is defined by the WHO as “an individual's 
perception of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards and concerns.”(49)  
 
In PRO research, the term „health-related quality of life (HRQoL)‟ is 
frequently utilized interchangeably with the term „QoL‟ to represent parts of QoL that 
relate to health or medical perspective.
(48, 50)
 HRQoL is defined by the International 
Society for Pharmacoeconomics and Outcomes Research (ISPOR) as “a broad 
theoretical construct developed to explain and organize measures concerned with the 
evaluation of health status, attitudes, values, and perceived levels of satisfaction and 
general well-being with respect to either specific health conditions or life as a whole 
from the individual‟s perspective.”(51) However, there has been growing consensus 
that there are clear distinctions between the two terms,
(52)
 and in order to obtain a 
more comprehensive assessment of the impact of a disease and its treatment on a 
patient‟s life, it is necessary to assess QoL.(52-54)   
 
Even though there are areas of dispute over the dimensions of QoL, most 
health care researchers do agree that QoL possesses the following characteristics: (a) 
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QoL is a subjective evaluation; (b) QoL is a multi-dimensional construct; and (c) QoL 
encompasses, at a minimum, three broad domains of health, i.e. physical, mental and 
social functioning.
(50, 55, 56) 
QoL has been widely recognized as one of the standard 
outcomes in the management of T2DM due to several obvious reasons. First, in the 
last two decades, healthcare delivery philosophy has shifted from the disease-centric 
approach towards the patient-centric approach where the patients‟ perspective is 
incorporated into healthcare decision making and chronic disease management. 
Therefore, greater emphasis has been placed on assessing the patients‟ QoL as well as 
other PROs such as treatment satisfaction.
(12, 18, 48, 57)
  
 
Second, as T2DM is still incurable at the moment, therapeutic interventions 
can only control the progression of the disease and prolong survival. On top of that, 
T2DM patients are required to comply with long-term treatments, some of which 
could probably cause significant adverse drug reactions (ADRs), side effects or even 
functional impairments that would worsen the patients‟ physical, mental and social 
well-being. Hence, QoL is undoubtedly an important outcome in T2DM care in 
addition to clinical outcome parameters such as glycated hemoglobin (HbA1c) and 
fasting plasma glucose (FPG) that are traditionally regarded as the principal endpoints 
of T2DM therapy.
(48, 55, 57) 
 
QoL instruments could be classified in several ways. To be appropriate for this 
thesis, we classify them into generic instruments and specific instruments (e.g. 
disease-specific, population-specific and function-specific).
(48, 57-59)
 Generic 
instruments are useful for comparisons across diseases, interventions and population 
groups. However, they may be less sensitive to small but clinically important changes 
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and fail to focus on the issues of interest in a particular disease or condition. Examples 
of generic instruments are the EuroQoL-5 Dimensions (EQ-5D), the Medical 
Outcomes Study Short-Form 36 (SF-36), the Nottingham Health Profile (NHP) and 
the Sickness Impact profile (SIP).
(59, 60)
 In contrast, specific instruments focus on 
areas of particular concern. For example, disease-specific instruments measure areas 
of life that are specifically affected by the disease of interest. They are more clinically 
sensible and have improved responsiveness compared to generic ones; however, they 
are restricted to only specific domains and do not allow cross-comparisons among 
diseases.
(57, 58, 60)
 Examples of DM-specific QoL instruments are the Audit of 
Diabetes-Dependent Quality of Life (ADDQoL), the Diabetes-39, the Diabetes Health 
Profile (DHP), the Diabetes Quality of Life Measure (DQOL) and the Diabetes-
Specific Quality of Life Scale (DSQOLS).
(58, 61)
 As there are advantages and 
disadvantages to both generic and specific instruments, utilization of both types of 





In addition to measuring the degree of QoL, it is important to identify factors 
potentially associated with this outcome. This would assist health professionals in 
planning care programs tailored to individual patients and focused on specific 
interventions for enhancing the patients‟ QoL.(62, 63) Previous studies have found that 
various patient demographic and clinical characteristics were significantly associated 
with poorer QoL in patients with DM, for example older age, female gender, obesity, 
insulin therapy and presence of complications/comorbidities.
(64-69) 
However, the 
results obtained from those studies were rather conflicting.  
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1.5.2. Treatment satisfaction as an outcome measure of T2DM management 
Treatment satisfaction is defined by Weaver et al.
(70)
 as “a recipient‟s rating of 
or report on salient aspects of the process and the result of his or her treatment 
experience according to predetermined criteria.” In their definition, treatments include 
“drugs, devices, procedures, therapies and health behavior modification.” According 
to the conceptual frameworks proposed by several researchers, treatment satisfaction 
could be influenced by a variety of factors including those related to patient, disease, 
healthcare system in general and treatment as follows.
(70-73)
 
- Patient: demographics, beliefs/prior expectations and intentions (i.e. 
willingness to take treatment or to continue therapy and personal preferences of 
therapy) 
-   Disease (clinical characteristics and duration of the disease) and treatment 
 history including experiences with previous treatments 
-  Healthcare system in general: access to therapy, patient-healthcare provider 
communication and information about treatment 
- Treatment: efficacy (onset/duration/extent of effects), side effects/ 
tolerability/discomforts with treatment, ease/convenience, flexibility and cost of 
treatment  
Treatment satisfaction is sometimes confused with the concepts of other PROs, 
especially QoL. However, regarding the previously described concept, treatment 




 Treatment satisfaction is considered a key outcome in T2DM management 
programs for a number of reasons.
(70-73)
 Firstly, it is likely to affect patient 
adherence/willingness to continue treatments and patient self-management, and could 
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possibly lead to improved clinical outcomes as patients satisfied with their treatments 
are likely to behave in ways that improve their health.
(71, 74, 75)
 Secondly, information 
on patients‟ satisfaction with treatment could facilitate patient-physician decision 
making on appropriate treatments, especially when there are several therapeutic 
options with similar efficacy available. An adequate understanding on the factors 
associated with treatment satisfaction would also enable health professionals to 
develop effective interventions or modify existing treatment plans to better address 
the needs and preferences of individual patients.
(69, 71, 76)
 Furthermore, assessment of 
treatment satisfaction and its associated factors could provide valuable information to 
providers in product development and marketing for improving their products as well 




With regards to measurement of treatment satisfaction in T2DM patients, there 
are a number of instruments available.
(77)
 Among them, some are specific to insulin 
therapies, for example, the Functional Insulin Treatment Satisfaction Questionnaire 
(DTSQ-for-FIT20 status and change versions), the Insulin Treatment Satisfaction 
Questionnaire (ITSQ) and the Patient Satisfaction with Insulin Therapy (PSIT) 
questionnaire. Other instruments are applicable to a wide range of DM medications, 
for example, the Diabetes Medication Satisfaction (DiabMedSat) questionnaire and 
the Diabetes Treatment Satisfaction Questionnaire – status (DTSQs) and change 
(DTSQc) versions.
(77)
 However, the domains commonly measured by both groups of 
treatment satisfaction instruments include: satisfaction with outcomes (onset of effect, 
efficacy and side effects), ease/convenience/flexibility of treatment, cost of treatment 
and overall satisfaction with treatment.
(71)  
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1.5.3. Improving the external validity of PRO instruments: the role of cross-
cultural adaptation  
Due to the fact that most PRO instruments were developed in one country 
before being adapted to another country, culture or language, a rigorous translation 
and adaptation process is essential to ensure that all translations are equivalent in all 
aspects to the original version and also culturally relevant and acceptable to the 
population in the target country. In that way, the PRO results of different national and 
cultural groups acquired from the use of the same instrument can be compared.
(78-83)
 
The process of translating and culturally adapting a PRO instrument from an original 
language to a target language is referred to as „cross-cultural adaptation.‟(83)  
 
 According to the ISPOR Principles of Good Practice,
(80)
 the cross-cultural 
adaptation process for PRO instruments comprises the following steps:  
1. Preparation – The researcher makes contact with the developer to ask for 
permission to use and translate the instrument, develops explanation of the concepts 
and recruits key persons concerned.   
2. Forward translation – It is generally agreed that at least two independent 
translators are needed for this step. They should be native speakers of the target 
language and have an experience in translating/adapting a PRO instrument. 
3. Reconciliation – This step aims to resolve discrepancies between the two 
forward translations and to produce a consensus version. 
4. Back translation – At least two back translators who are native speakers of 
the original language and fluent in the target language are required to independently 
translate the reconciled version back into the source language version. To avoid biases, 
they should not be aware of the intent of the original instrument.  
Chapter 1. Introduction                                                                                Pongmesa, Tipaporn 
  15 
5. Back translation review - The back translations are reviewed against the 
original version so that any deviations from the conceptual meaning of the instrument 
would be detected. This step is useful for reducing the ambiguity in difficult concepts, 
suggesting possible revisions, and then leading to an improved reconciled version.  
6. Harmonization – This step helps in ensuring conceptual equivalence 
between the current translation, original version and also previously developed 
versions, thus allowing reliable aggregation of data from global clinical trials.  
7. Cognitive debriefing – This step involves native speakers of the target 
language who are good representatives of the target population (three to ten, or five to 
eight respondents, depending on the guidelines). It begins from the respondents self-
completing the translated instrument, and then is followed by an item-by-item 
interview to detect the respondents‟ interpretation of the translation. This step is 
useful to ensure that the translation is understandable and acceptable to the target 
population.  
8. Review of cognitive debriefing results and finalization – The results 
obtained during the cognitive debriefing are reviewed against the original version. 
Revisions to the translation are allowed if deemed necessary to improve its 
performance. 
9. Proofreading – Before the translated instrument is approved for use, it 
should be checked for any errors that may be missed during the previous steps.  
10. Final report – A complete description of every step taken should be 
included in the final report to facilitate the translation and harmonization of the same 
instrument in the future. 
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Although the cross-cultural adaptation process may help to ensure equivalence 
between the original and the adapted versions, it cannot guarantee that the 
measurement properties of the instrument would be retained. Hence, psychometric 
evaluation which is an assessment of an instrument‟s measurement properties (e.g. 
validity and reliability) should be performed before the utilization of the adapted 
instrument in clinical settings.
(83)
 A brief description of the two measurement 
properties being evaluated in this thesis is provided as follows. 
 
Validity 
 Validity is defined as “the extent to which an instrument measures what it is 
intended to measure.”(60) It can be divided into various aspects, namely content 
validity, construct validity and criterion validity.
(57, 60, 84)
 Content validity indicates 
whether the contents or domains of an instrument are adequate, representative and 
relevant to what it is supposed to measure.
(57) 
Face validity is considered an aspect of 
content validity and refers to the degree to which items in an instrument cover the 
intended topics clearly and unambiguously on its face.
(84)
 Construct validity indicates 
the degree to which an instrument can measure the hypothetical constructs that it has 
been designed to measure.
(57, 84)
 There are several forms of construct validity, namely 
known-groups validity, convergent validity and discriminant validity.
(50, 63)
 Criterion 
validity refers to the performance of an instrument against the true value that it is 
intended to assess or against a „gold standard‟ measure in the field.(50, 63) It is often 
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Reliability 
Reliability refers to the reproducibility and consistency of the results obtained 
from the use of an instrument.
(50, 63)
 There are two forms of reliability, namely internal 
reliability (internal consistency) and repeatability.
(57)
 For internal consistency, 
individual items in a scale that contains multiple items are assumed to be consistent 
with each other.
(57)
 Cronbach‟s alpha coefficient is commonly used to estimate this 
item-to-item correlation, and a reliability level of 0.7 is generally considered 
acceptable for group comparisons in clinical trials while the level of 0.9 is 
recommended for individual assessments.
(85)
 Repeatability refers to the correlation 
between repeated measurements and includes several forms, for example, test-retest 




1.6. Research objectives and thesis organization 
From the brief overview, research gaps identified for T2DM management in 
Thailand are summarized below.  
 Public health education is a key factor for the successful management of T2DM. 
For planning an effective health education program, information on the level of DM 
knowledge among the targeted population is necessary. However, to the best of our 
knowledge, no published study on public knowledge of DM in Thailand is available. 
 Despite the fact that QoL and treatment satisfaction are recognized as important 
outcomes in DM care, little is known about these outcomes in patients with DM in 
Thailand.   
 A generally accepted norm in QoL research is the utilization of both generic and 
disease-specific instruments to complement each other.
(58, 60, 61)
 However, while 
several generic QoL instruments are available in the Thai language, no Thai version 
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of a DM-specific QoL instrument is currently available. This leads to the necessity to 
find a culturally adapted and validated DM-specific QoL instrument for use among 
Thai DM patients.  
 Currently, a linguistically validated Thai version of a DM-specific treatment 
satisfaction instrument, namely the Diabetes Treatment Satisfaction Questionnaire 
(DTSQ) is available. However, information on its psychometric properties among 
Thai patients with DM is still lacking. 
 
Based on the aforementioned gaps, the main objective of the current thesis is 
to explore the feasibility of improving the management of T2DM in Thailand using 
outcomes research. This thesis can be broadly separated into two main sections with 
their specific objectives. The first section concerns public health education on DM 
and it aims to:    
 evaluate the level of DM knowledge among the Thai public. 
 identify specific aspects of DM knowledge that need further strengthening for a 
targeted education effort.  
 identify people‟s characteristics potentially associated with knowledge of DM.  
 compare the level of DM knowledge among the residents in Bangkok (the capital 
and the largest city in Thailand) and that of the residents in other central provinces.  
 
The second section focuses on the measurement of PROs in patients with DM. 
The objectives of this section are to: 
 cross-culturally adapt a Thai version of a DM-specific QoL instrument, namely 
the Audit of Diabetes-Dependent Quality of life (ADDQoL-19) and evaluate its 
psychometric properties among DM patients in Thailand. 
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 evaluate psychometric properties of a Thai version of a DM-specific treatment 
satisfaction instrument, namely the Diabetes Treatment Satisfaction Questionnaire 
status version (DTSQs). 
 assess health status, QoL and treatment satisfaction of patients with DM in 
Thailand using the Thai versions of the EQ-5D, the ADDQoL-19 and the DTSQs and 
to identify factors potentially associated with these PROs.  
 assess the association between polypharmacy and QoL. 
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2.1. INTRODUCTION 
With its dramatically increasing global prevalence rate, diabetes mellitus 
(DM) is one of the major public health concerns worldwide. The estimated prevalence 
rate of DM was 2.8% of the total world population (or 171 million sufferers) in 2000 
and is projected to increase to 4.4% (or 366 million sufferers) by 2030, due to a 
combination of population ageing, urbanization and higher prevalence of obesity.
(86, 
87) 
Although DM is currently more prevalent in developed countries, its proportional 
increase is higher in developing world with the highest increase in India and China.
(88, 
89)
 DM is also one of the most prevalent chronic diseases in Thailand, with 
approximately 1.5 and 2.7 million sufferers estimated in 2000 and 2030, 
respectively.
(90) 
Similarly, DM was the fourth leading cause of death, accounting for 
5% of all causes of death in Thailand in 2002.
  
 
Being a chronic disease with many devastating complications, DM naturally 
places substantial clinical and financial burden on any healthcare systems. Even 
though sufferers often die of other complications, especially cardiovascular and renal 
diseases, thus making an accurate estimation of DM mortality difficult,
(4)
 DM is still 
ranked as one of the major causes of premature death in many countries.
(91)
 The 
global mortality attributable to DM was estimated to be 987,000 deaths or 1.7% of the 
total world mortality in 2002.
(4)
 In addition, as type 2 DM (T2DM) has an insidious 
and slow onset, many people are not aware that they have developed the disease until 
symptoms of its complications appear.
(92)
 Major DM complications can result in 
disability, decreased productivity/quality of life (QoL) and even increased 
mortality.
(93)
 However, more worrisome to healthcare providers is an obvious trend of 
downward age shift with T2DM increasingly diagnosed among younger adults.
(94)
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Considering the impact of lifestyle on development of T2DM, this would 
signify a need for a re-evaluation of the effectiveness of public health education about 
DM. Undeniably, public health education is a key factor for the successful 
management and control of T2DM.
(34)
 Increasing the level of public knowledge on 
DM could contribute to an improved overall health behavior of the society, with its 




Therefore, information on public knowledge of DM will be useful for planning 
an effective education program. However, although many studies on DM knowledge 
have been conducted, most of them focused only on DM patients and not the general 
population.
(31)
 Furthermore, the results obtained from the few studies evaluating DM 
knowledge among the general population in different countries were inconsistent. For 
example, a study in Singapore in 1999 found that the public there generally had 
adequate knowledge of DM.
(30)
 In contrast, a study in India in 2004 showed that 
awareness of DM in the general population was poor;
(47)
 similar to the finding of 
another study conducted in Iran in 2005.
(36)
 Even though the inconsistency may reflect 
the different levels of success in public education on DM, other factors could also be 
contributive and then it is difficult to generalize the results to different geographic 
settings. Hence, local studies are warranted for a more accurate assessment of the 
areas of success and deficiencies to facilitate the planning and delivery of an effective 
DM education program. 
 
To the best of our knowledge, up to now, there is no published study on the 
level of DM knowledge in the Thai public. Thus this study was conducted with the 
aims to evaluate knowledge on DM among the general population in the central 
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region of Thailand and to identify areas of knowledge deficiency requiring additional 
education effort. In addition, we also evaluated whether factors such as gender, age, 
education level, own self having DM and having a family member/relative/friend with 
DM are associated with knowledge of DM in this population. 
 
2.2. METHODS 
2.2.1. Study locations 
This was a cross-sectional survey conducted in the central region of Thailand 
during June to July 2007. The study areas were Bangkok (the capital) and four other 
provinces, namely Nakhon Pathom, Nonthaburi, Pathum Thani and Samut Sakhon. 
For Bangkok, the following fifteen districts were selected from among fifty districts 
with the aim to cover as wide a geographical region of Bangkok as possible: Bang 
Kae, Bang Khen, Bang Na, Bangkok Noi, Huai Khwang, Khong Sam Wa, Lat 
Krabang, Lat Phrao, Pathum Wan, Phasi Charoen, Phra Nakhon, Prawet, 
Ratchathewi, Rat Burana and Thon Buri. For the four other provinces, sub-districts 
that are considered highly urbanized and those connected to Bangkok were excluded.  
 
In order to get as representative a sample as possible, we recruited respondents 
from public areas such as bus stops, boat stations, train stations, walkways to 
Bangkok Mass Transit System (BTS) SkyTrain stations (in Bangkok), markets and 
supermarkets, at various time of the day during weekdays and weekends. Permission 
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2.2.2. Respondent recruitment 
The survey targeted to recruit a total of 1,000 respondents with 33 to 34 
respondents from each district of Bangkok and 125 respondents from each of the four 
provinces. One in every ten people passing by the study locations was approached. 
The inclusion criteria were: Thai residents aged 15 years and above; residents of the 
area; and had no obvious incoherence in speech and/or thoughts. After an explanation 
of the purpose of the study, the respondents were offered the option of either self-
administration or interview as mode of questionnaire completion, thus allowing the 
inclusion of respondents who were elderly, with visual problems and/or illiterate, 
groups that were more likely to have poorer knowledge of DM.  
 
The interviewers comprised of one of the investigators, four final year 
undergraduate pharmacy students from Silpakorn University, five pharmacists and 
five temporary staffs. To minimize interviewer biases, all interviewers were well 
trained in interview techniques and provided with an introductory sheet as well as an 
interview protocol before study initiation. It was emphasized that the interviewers 
were not to provide the answers or any clues to the questions until the respondents 
had already handed in the questionnaire. After each survey, the interviewers checked 
the questionnaires for completeness and identifying obvious inconsistency so that they 
could ask the respondents to fill in missing responses or revise apparently inconsistent 
responses promptly.  
 
2.2.3. Survey instrument 
The questionnaire used in the survey was translated and culturally adapted 
from the General Diabetes Knowledge Test, a published English questionnaire 
 Chapter 2. A survey of knowledge on diabetes in Thailand                       Pongmesa, Tipaporn 
 25  
previously used in Singapore.
(30)
 Two translators and two pharmacy academics were 
involved in standardized forward and back translation of the questionnaire into Thai. 
Modifications were needed for some items as several words and phrases were found 
to be difficult to translate into Thai. The translated questionnaire was then reviewed 
by a doctor, two pharmacists, two pharmacy academics and one of the investigators 
for completeness, appropriateness and ease of understanding. Some items, especially 
those in the demographic section, were modified or even removed to make the 
questionnaire more relevant to the Thai respondents. For example, the phrase 
“carrying sweets and jelly beans” was modified to “carrying candies” as jelly beans 
are not popular in Thailand, and the word “candies” is more suitable in this context. 
For an item in the risk factor section, “age above 40 years old” was changed to “age 
45 years old or above” to reflect the updated information from the American Diabetes 
Association (ADA)‟s Standards of Medical Care in Diabetes 2006.(95) In addition, 
several items were added to acquire more information from the respondents, for 
example, the item “Have you ever been diagnosed of DM?” The Thai version was 
revised until consensus was achieved among all persons involved.  
 
A pilot study to evaluate this initial Thai version was undertaken in twenty-
five Thai adults who were members of the public recruited during the Pharmacy week 
at Silpakorn University in Thailand. There was no further modification, and the final 
version of the questionnaire comprised seven sections: sociodemographics (9 items); 
general knowledge of DM (8 items); risk factors (4 items); symptoms and 
complications (11 items); treatment and management (11 items); monitoring (5 
items); and DM in women (3 items). It comprised both close-ended questions, with 
the response options “Yes,” “No,” and “Don‟t know,” and some open-ended questions 
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to acquire some information in detail. The “Don‟t know” option was included to 
reduce the amount of guess work from respondents. The respondents were awarded 
one point for each correct response, and zero for each wrong or “Don‟t know” 
response. As the first section was not scored, the maximum possible score for the 
questionnaire was 42. Percentage scores were converted from raw scores using the 
following formula: (raw score x 100)/maximum possible score. 
 
To establish experts‟ opinions on appropriate grading criteria for DM 
knowledge scores based on our questionnaire, a Delphi study was conducted among 
five endocrinologists in Thailand. After the third round, consensus (i.e. agreement of 
80% or above) was achieved for all items discussed. DM knowledge score of <50%, 
>50% to <80% and >80% of the total score was defined as poor, fair and good, 
respectively. If an individual scored at least 50% of the total score, his/her knowledge 
on DM was considered acceptable. The expert panel also agreed that it was 
appropriate to provide the same weight (one point) to all items in the questionnaire. 
Furthermore, similar to the lay persons in the pilot study, the experts agreed that the 
contents of this questionnaire were complete in its coverage of important aspects of 
knowledge on DM that should be included in a public education program. 
 
2.2.4. Hypotheses  
Hypotheses tested in the current study were: 
1. Respondents with DM would have better knowledge of DM than their non-
DM counterparts,
(28, 31, 41, 47)
 given that the former would have been exposed to the 
actual management of DM, and that they are likely to have received further patient 
education as part of their disease management.  
 Chapter 2. A survey of knowledge on diabetes in Thailand                       Pongmesa, Tipaporn 
 27  
2. Education level would be associated with knowledge of DM,(28, 29, 31-44, 46, 47) 




3. Respondents who have a family member/relative/friend with DM would have 
higher level of knowledge on DM,
(29, 31, 32, 39, 41, 47)
 for reasons similar to hypothesis 
no.1.  
4. Older age would be negatively correlated with knowledge of DM,(29, 33, 34, 36-43) 




5. Gender would be associated with knowledge of DM, with female having 
poorer knowledge,
(32, 33, 35, 36)
 based on existing literature suggesting gender disparity 




2.2.5. Statistical analyses  
All data were analyzed using SPSS version 15.0 (SPSS Inc., Chicago, IL, US). 
Random checks were performed to detect errors in data entry. Univariate analyses 
using either the Student‟s t-test or the one-way analysis of variance (ANOVA) were 
used to assess the associations between DM knowledge score and individual 
variables, except for age which was assessed by linear regression analysis as it was 
treated as a continuous variable. For income, the value of 15,000 Thai Baht (THB; 
approximately 441.2 USD) was used as the cut-off level in this study because people 
earning less than 15,000 THB per month are generally considered as low income 
group in Thailand.
(99)
 The variables found to be significant in univariate analyses were 
further included in multiple linear regression (MLR) analyses where the associations 
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were evaluated while adjusting for potential confounders. The significance level was 
set at 5%, unless otherwise stated.  
 
2.3. RESULTS  
2.3.1. Characteristics of study respondents   
A total of 1,000 respondents were recruited as intended. The participation rate 
was about one in every five people approached in Bangkok, and one in every three 
people approached in other provinces. Most respondents completed the survey by 
self-administration (81%). Mean age of respondents who preferred self-administration 
(29.88 years, SD=10.17) was significantly lower than those who preferred interview 
mode (50.57 years, SD=12.77, p<0.001). Likewise, mean years of education between 
the two groups was significantly different, with more years in the self-administration 
group (15.61 years, SD=2.86 vs. 8.90 years, SD=4.10, p<0.001). Interviewer effect 
was investigated using MLR analysis and was found to be insignificant (p=0.934). 
There were statistically significant differences in overall scores between respondents 
who completed the survey by self-administration (25.34 [60.33%], SD=8.05 
[19.17%]) and by interview (23.68 [56.38%], SD=9.43 [22.45%], p=0.026). However, 
as excluding those subjects who completed the survey by interview made little 
difference to the findings, data were combined for all respondents. The age of the 
pooled sample ranged from 15 years to 85 years. Among the respondents, 3.6% had 
DM, with a mean (SD) disease duration of 7.76 (7.98) years. Characteristics of the 
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                  Table 2.1:     Characteristics of respondents (N=1,000)  
 
 
Characteristic N (%) 
Gender  
  Male   425 (42.5)  
Female 575 (57.5)  
Age   
  Mean (SD) 33.81 (13.44)  
Education level   
  None/Elementary 145 (14.5) 
  Lower secondary  124 (12.4) 
  Upper secondary 327 (32.7) 
  Bachelor‟s or higher 404 (40.4) 
Mean (SD) years of education  14.33 (4.09) 
Working status    
  Currently working  780 (78.0)  
  Does not work/Retired 220 (22.0) 
Income level (in THB)*  
  None 195 (19.5) 
  <15,000 535 (53.5) 
  >15,000 270 (27.0) 
Own self having DM  
  Yes 36 (3.6) 
  No 964 (96.4) 
Having a family member/relative/friend with DM 
  Yes        570 (57.0) 
  No                                                                        430 (43.0) 
Mode of questionnaire administration  
  Self-administration  810 (81.0) 
  Interview 190 (19.0) 
             
  THB=Thai Baht 
* 33.15 THB is approximately equal to 1 USD (data on December 3,  
2009). 
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2.3.2. Knowledge of various aspects of DM  
From a maximum possible score of 42, the mean (%) score of the respondents 
was 25.02 (59.57%) (SD=8.35 [19.88%]) with a score range of 0 to 42. The 
distribution of the respondents‟ overall scores is shown in Figure 2.1. 
 
 






























































According to the grading criteria established, 26.9%, 58.8% and 14.3% of the 
respondents were considered to have “poor,” “fair” and “good” knowledge of DM, 
respectively. The respondents‟ performances in each section of the questionnaire are 
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 II.  General knowledge of DM 8 3.80 (2.03) 47.50 (25.38) 
 III. Risk factors  4 2.88 (1.11) 72.00 (27.75) 
 IV. Symptoms and complications  11 6.38 (2.99) 58.00 (27.18) 
 V.  Treatment and management  11 7.69 (2.61) 69.91 (23.73) 
VI.  Monitoring  5 3.46 (1.43) 69.20 (28.60) 
VII. DM in women 3 0.82 (0.96) 27.33 (32.00) 
 
* Section I is the sociodemographic section 
† 
Mean percentage score expressed as mean section score over maximum section 




The respondents performed best in the risk factor section with a mean score of 
2.88 out of 4 (72.00%) (SD=1.11 [27.75%]). Sedentary lifestyle, obesity and having a 
family history of DM were well recognized as risk factors of DM. However, only half 
of the respondents knew that older age is another risk factor of DM (Table 2.3). Slow 
healing of cuts and wounds, constant tiredness/fatigue and frequent urination were 
generally well recognized as symptoms of DM. Majority of the respondents however 
did not know that unexplained weight loss is also a DM symptom. With regards to 
DM complications, although most of the respondents (74.8%) were aware that chronic 
ulcers could be a result of DM, fewer than half (44.2%) knew that nephropathy is also 
a complication of DM.  
 
The respondents‟ knowledge of treatment and management of DM was fair, 
with a mean score of 7.69 out of 11 (69.91%) (SD=2.61 [23.73%]) (Table 2.2). The 
only one item that most respondents failed to provide the correct answer was the 
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recommendation for people with DM to carry candies when going out (Table 2.3).  
Knowledge of DM monitoring was also fair, with a mean score of 3.46 out of 5 
(69.20%) (SD=1.43 [28.60%]) (Table 2.2). However, approximately 40% of the 
respondents did not know the need for renal function tests and regular eye check-up in 
DM monitoring (Table 2.3). 
 
Knowledge deficit was most apparent in the section on DM in women, with a 
mean score of 0.82 out of 3 (27.33%) (SD=0.96 [32.00%]) and less than 40% correct 
answers given to all items (Table 2.3). In addition to this section, the general 
knowledge of DM section is the other one with a mean score of less than 50% (3.80 
out of 8 [47.50%], SD=2.03 [25.38%]) (Table 2.2). Although most respondents knew 
what DM is and that it is non-contagious, less than 50% of them (n=494 of the 1,000) 
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N (%)  
Correct Wrong Don't know 
Section II. General knowledge of DM*    
 
DM  is:     
1. a condition of high blood sugar 847 (84.7) 34 (3.4) 119 (11.9) 


















4. a non-contagious disease 747 (74.7) 89 (8.9) 164 (16.4) 
5. a non-curable disease
†
   494 (49.4) 255 (25.5) 248 (24.8) 
    
Insulin:     
6. is a kind of hormone
†
   255 (25.5) 192 (19.2) 552 (55.2) 
7. controls blood sugar level 584 (58.4) 21 (2.1) 395 (39.5) 
8. is required for some patients with DM
†
 223 (22.3) 218 (21.8) 558 (55.8) 
 
Section III. Risk factors     
    
A person is more likely to get DM if he/she:    
1. lacks exercise 807 (80.7) 110 (11.0) 83 (8.3) 
2. has a family history of DM 810 (81.0) 91 (9.1) 99 (9.9) 
3. is 45 years old or above
†
 499 (49.9) 280 (28.0) 220 (22.0) 
4. is obese
†
   767 (76.7) 125 (12.5) 107 (10.7) 
 
Section IV. Symptoms and complications     
    
Symptoms of DM include:    
1. constant thirst
†
 416 (41.6) 121 (12.1) 462 (46.2) 
2. frequent urination 650 (65.0) 67 (6.7) 283 (28.3) 
3. unexplained weight loss 229 (22.9) 421 (42.1) 350 (35.0) 
4. blurred vision 572 (57.2) 79 (7.9) 349 (34.9) 
5. slow healing of cuts and wounds  886 (88.6) 24 (2.4) 90 (9.0) 
6. constant tiredness/fatigue 745 (74.5) 32 (3.2) 223 (22.3) 
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Table 2.3:     The respondents’ scores in each item (continued) 
 
Item N (%) 
 Correct Wrong Don't know 
 
Section IV. Symptoms and complications (continued) 
 
Complications of DM include:     
7. numbness in hands and feet 526 (52.6) 74 (7.4) 400 (40.0) 
8. retinopathy 627 (62.7) 59 (5.9) 314 (31.4) 
9. nephropathy 442 (44.2) 113 (11.3) 445 (44.5) 
10. cardiovascular disease
†
 534 (53.4) 85 (8.5) 380 (38.0) 
11. chronic ulcers especially on the feet
†
 748 (74.8) 55 (5.5) 196 (19.6) 
    
Section V. Treatment and management     
    
Medications for controlling DM are:    
1. insulin injections 495 (49.5) 40 (4.0) 465 (46.5) 
2. oral tablets/capsules 584 (58.4) 38 (3.8) 378 (37.8) 
 
Lifestyle measures patients with DM should 
take are: 
   
3. always carry candies when they go out
†
 386 (38.6) 311 (31.1) 302 (30.2) 
4. exercise regularly
†
 882 (88.2) 27 (2.7) 90 (9.0) 
5. control their weight
†
   876 (87.6) 25 (2.5) 98 (9.8) 
6. have low fat diet
†
 686 (68.6) 113 (11.3) 199 (19.9) 
7. do not skip any meals
†
 665 (66.5) 96 (9.6) 238 (23.8) 
8. do not drink alcoholic beverages
†
 764 (76.4) 98 (9.8) 137 (13.7) 
9. do not smoke cigarette
†
 804 (80.4) 70 (7.0) 125 (12.5) 
10. take care of their feet very well 805 (80.5) 74 (7.4) 121 (12.1) 
11. do not wear tight shoes  742 (74.2) 39 (3.9) 219 (21.9) 
    
Section VI. Monitoring     
    
Patients with DM should monitor the 
progression of their DM by: 
   
1. testing blood glucose 940 (94.0) 6 (0.6) 54 (5.4) 
2. testing renal function  573 (57.3) 108 (10.8) 319 (31.9) 
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Table 2.3:     The respondents’ scores in each item (continued) 
 
Item N (%) 
 Correct Wrong Don't know 
 
Section VI. Monitoring (continued)    
 
3. testing proteinuria 580 (58.0) 95 (9.5) 325 (32.5) 
4. regular eye check-up 557 (55.7) 136 (13.6) 307 (30.7) 
5. checking blood pressure 810 (81.0) 38 (3.8) 152 (15.2) 
    
Section VII. DM in women    
    
Women with DM:    
1. can take oral contraceptive pills 222 (22.2) 97 (9.7) 681 (68.1) 
2. have a potentially increased risk of giving 
















* Section I is the sociodemographic section. 
†




2.3.3. Responses to open-ended questions 
Table 2.4 lists other risk factors of DM as mentioned by the respondents, with 
high-sugar diet and hypertension being the most commonly mentioned (1.2 and 0.6%, 
respectively). For other treatments for DM, various Thai and Chinese herbal 
medicines were mentioned by approximately 2% of the respondents while 
antihypertensive agents, antihyperlipidemic agents and liver supplements were also 
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Table 2.4:    The list of other risk factors of DM as mentioned by the respondents 




Foods   
Bad habit in eating; Drink beers too much; Eating too much; Fatty diet; Foods with 
too strong tastes; High-starch diet; High-sugar diet; Inappropriate foods; Inadequate 
consumption of vegetables; Salty diet  
 
Diseases/Abnormalities/Disorders  
Abnormal insulin secretion; Bruising of nerve cell(s); Having too high level of blood 
sugar; Heart disease; Hyperlipidemia; Hypertension; Inflamed wound; Lack of 
insulin hormone; Pancreas inflammation/abnormality; Renal disease 
 
Others 
Do not take care of health; Lack of nutritional supplements; Inadequate rest; Some 





Table 2.5:    The list of other treatments for DM as mentioned by the respondents 




Herbs and herbal medicines: “Bai khoi dam” (Siamese rough bush leaves)*; “Bai 
Hoo Kwang” (Bengal almond leaves); Green tea; “Khafag Ma Muang”(Dendrophthoe 
pentandra)
†; “Kra Doom Thong”(Little yellow star flower)*; Kratom; Lime; “Ya 
Look Klon” (ball-shaped herbal pills) 
 
Others:  Antihypertensive agents; Antihyperlipidemic agents; Liver supplements 
 
 
* Local name followed by English common name 
†
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With regards to major sources of DM information, friends or relatives and the 
mass media were most frequently reported (60.1%). Only approximately one-third of 
the respondents (35.8%) reported healthcare professionals as their major information 
sources (Figure 2.2). As high as 60.5% of the respondents reported that they had 
never received recommendations about DM from any healthcare professional while 
28.1%, 10.7% and 6.4% of the respondents reported previous recommendations from 
doctors, nurses and pharmacists, respectively (more than one option allowed). In 
addition, approximately 10% of the respondents knew the existence of DM 
organizations/support groups for people with DM in Thailand; however, only a small 
number of them were able to recall a name of those organizations. Surprisingly, less 
than 1% of the respondents mentioned the Diabetes Association of Thailand.  
 
 
Figure 2.2:    Major sources of DM information of the respondents (more than 
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2.3.4. Factors associated with knowledge of DM  
Table 2.6 shows associations between respondents‟ characteristics and 
knowledge on DM in univariate analyses. As hypothesized, higher education level, 
own self having DM and having a family member/relative/friend with DM were 
significantly associated with better knowledge of DM. In addition, income level and 
mode of questionnaire administration were also found to be significant factors. 
However, in contrast to our hypotheses, older age was positively associated with DM 
knowledge, and gender was not a significant factor although we found that females 
were likely to score higher than males.  
 
In MLR analysis, only age, years of education, own self having DM and 
having a family member/relative/friend with DM remained statistically significant in 
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Table 2.6:     Evaluation of potential factors associated with knowledge on DM of 








Gender    
  Male   24.58 (8.39) 58.52 (19.98) 
0.147 
  Female 25.35 (8.31) 60.36 (19.79) 
Age     
  Coefficient (SE) 0.053 (0.020) 0.007 
Education level     
  None/Elementary 22.36 (9.81) 53.23 (23.36) 
<0.001 
  Lower secondary  23.05 (8.63) 54.88 (20.54) 
  Upper secondary  23.96 (8.20) 57.05 (19.53) 
  Bachelor‟s or higher 27.44 (7.12) 65.34 (16.95) 
Working status     
  Currently working  25.10 (8.48) 59.76 (20.19) 
0.597 
  Does not work/Retired 24.76 (7.87) 58.95 (18.74) 
Income level (in THB)
† 
    
  None 24.26 (7.98) 57.76 (19.00) 
<0.001   <15,000 24.27 (8.50) 57.79 (20.24) 
  >15,000 27.06 (8.00) 64.43 (19.05) 
Own self having DM    
  Yes 29.28 (5.20) 69.71 (12.38) 
<0.001 
  No 24.86 (8.40) 59.19 (20.00) 
Having a family member/relative/ 
friend with DM 
  
  Yes        26.62 (7.70) 63.38 (18.33) 
<0.001 
  No                                                                        22.90 (8.71) 54.52 (20.74) 
Mode of questionnaire administration   
  Self-administration  25.34 (8.05) 60.33 (19.17) 
0.026 
  Interview 23.68 (9.43) 56.38 (22.45) 
 
SE=Standard error; THB=Thai Baht  
* Mean percentage score expressed as mean overall score over maximum overall 
score (42) multiplied by 100 (e.g. 24.58/42*100=58.52). 
† 
33.15 THB is approximately equal to 1 USD (data on December 3, 2009). 
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Table 2.7: Multiple linear regression analysis of factors associated with   
knowledge of DM 
 
 
Factor Coefficient Standardized 
coefficient 
p-value 
(Constant) 12.659 - <0.001 
Age (years) 0.079 0.127 0.003 
Years of education 0.535 0.262 <0.001 
Income <15,000 THB* 0.364 0.022 0.594 
Income >15,000 THB* 0.636 0.034 0.449 
Own self having DM 2.867 0.064 0.047 
Having a family member/relative/ 







    
Self-administration
† 
 0.083 0.004 0.934 
 
   Dependent variable: Overall score 
   THB=Thai Baht 
   * 33.15 THB is approximately equal to 1 USD (data on December 3, 2009);  
     „No income‟ was the reference group for income level.  





2.4.1.   Knowledge of various aspects of DM  
In this study of 1,000 Thai respondents, we sought to evaluate the level of 
knowledge of DM among the population in the central region of Thailand and found 
this to be fair (according to Delphi panel‟s criteria). This suggests a need to further 
strengthen knowledge of DM among the general public.  
 
We also sought to identify areas of knowledge deficiency to inform future 
educational effort. It is promising that the respondents performed best in the risk 
factor section, as an understanding of the risk factors is likely to heighten awareness 
about the importance of prevention of T2DM. This is also consistent with the fact that 
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public DM education programs in Thailand have traditionally focused on risk factors. 
Incidentally, the frequent citing of high-sugar diet as a risk factor of DM highlights a 
common misconception requiring corrective actions.  
 
It is also encouraging that the respondents generally had a good understanding 
of DM symptoms as this would allow the general public to detect the disease early. 
The finding that unexplained weight loss was not widely recognized as a symptom of 
DM may be due to the fact that it is a less common symptom,
(1)
 and T2DM usually 
develops in overweight or obese individuals. Our study suggests a need to increase 
awareness of renal complications of DM. Awareness of DM complications is 
important in at least two ways: (1) heighten the need for T2DM prevention and early 
diagnosis among the general public; and (2) heighten the need for disease control 
among individuals with TDM. In addition, the need for renal function tests and 
regular eye check-up in DM monitoring should be further emphasized. With this 
knowledge, friends and family members of people with DM could also help improve 
compliance with these regular tests that are useful in early identification and 
management of DM complications.  
 
With regards to knowledge on treatment and management of DM, a possible 
reason for an acceptable performance in this area is that a sizable portion of our 
respondents had a family member/relative/friend with DM. Furthermore, a number of 
those respondents informed that they were responsible in taking care of their family 
members who had DM. Incidentally, our study suggests that the recommendation for 
people with DM to carry candies when going out may be an important issue to 
emphasize in future education programs, particularly for patient education. In 
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addition, public education effort with regards to the use of Thai and Chinese herbal 
medicines should be strengthened as, according to evidence-based practice, the 
efficacy of these herbal medicines in treating DM has not been proven. This 
misconception may render people with DM to rely on herbal medicines rather than 
their prescribed antidiabetes medications, with potentially dire consequences.  
 
Given that the respondents performed poorly in other areas of the survey, it is 
possibly timely to re-evaluate the current focus and strategies of public DM education 
programs in Thailand. The misconception that DM is curable requires an urgent 
correction as people may neglect to take measures to reduce risk of developing 
T2DM. Additionally, many wrong answers given to the items concerning insulin 
could imply that majority of the public do not know about insulin. Actually, this 
finding is rather surprising given that a sizeable portion of our respondents had a 
family member/relative/friend with DM. The issues of DM in women and gestational 
DM are often neglected in public education effort, and this is reflected in the very low 
score obtained by the respondents in the section on DM in women. As gestational DM 
is strongly associated with the risk of DM in future offspring,
(100)
 knowledge in this 
area needs to be strengthened.  
 
2.4.2. Major sources of DM information and DM organizations/support groups 
for people with DM  
Our finding that friends, relatives and the mass media were the most important 
sources of DM information among our study population is similar to the finding of the 
study of Wee et al. in Singapore.
(30)
 This provides some food for thoughts regarding 
the visibility, effectiveness, and possibly approachability of healthcare professionals 
 Chapter 2. A survey of knowledge on diabetes in Thailand                       Pongmesa, Tipaporn 
 43  
as sources of DM information. While many healthcare professionals are keen to play a 
more active role in providing DM information to the general population, the means by 
which they do so need to be better designed.  
 
While Wee et al.
(30)
 found that very few Singaporean respondents were aware 
of the existence of DM organizations/support groups in Singapore, a number of 
respondents in our study knew of these organizations in Thailand. However, the 
finding that most respondents could not recall the names of those organizations 
suggests that the organizations should increase their visibility and establish a clear 
identity to meet their mission in improving lives of people with DM in Thailand.  
 
2.4.3.  Factors associated with knowledge of DM  
Our finding that higher education was associated with better knowledge of 
DM is in lines with previous studies,
(29, 31-44, 46, 47)
 and highlights the need for much 
additional effort to be put on providing health education programs for less educated 
groups. Likewise, a far better knowledge of DM among the respondents with a family 
member/relative/friend with DM than those without in our study is consistent with a 
number of studies.
(29, 31, 32, 39, 41, 47)
 Our study also provided more evidence supporting 
the results from several studies
(28, 31, 41, 46) 
that people with DM were much more 
knowledgeable about DM than their healthy counterparts. Actually, this finding is 
unsurprising due to several following reasons. First, patients are likely to be more 
informed about DM from healthcare professionals during their clinic visits. Second, 
they are possibly keener to learn more about their clinical conditions as well as 
potential complications of DM. A number of healthy respondents in our study 
admitted that they had never paid attention to any DM information provided since 
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they thought it was not relevant to them, and they were also unaware of serious 
consequences of DM. This highlights the need for more targeted education campaigns 
on DM as well as its devastating complications to enhance awareness of the disease in 
apparently healthy population.  
 
The current literature evaluating the associations between other demographic 
characteristics and knowledge of DM yielded mixed findings, suggesting the need for 
further elucidation. While some studies reported that gender was a determinant of 
knowledge on DM,
(32-36)
 our study yielded a similar result with a number of studies 
that gender was not a statistically significant factor.
(31, 39, 40, 44, 46, 47) 
A positive 
association between age and knowledge of DM in our study is in agreement with 
several studies.
(44-46)
 However, many studies found lower level of DM knowledge in 
older people,
(29, 33, 34, 36-43)
 and a number of studies revealed no association between 




2.4.4. Study strengths and limitations  
An important strength of this study lies in the use of expert consensus on the 
appropriate grading criteria of DM knowledge scores assessed with our study 
questionnaire. In most published studies, researchers often concluded that the 
knowledge scores achieved were “acceptable/satisfactory” or “poor” without 
providing any criteria for their interpretations, with a score of 50% found to be the 
most commonly utilized (either explicitly or implicitly) cut-off.
(32, 40, 46)
 In the few 
studies that specified the criteria, the details of how those criteria were developed 
were not available. For example, Kamel et al.
(40)
 described the percentage of score 
<50%, 50% to 75% and >75% as “poor,” “satisfactory” and “very good” knowledge 
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levels, respectively, without an explanation for the cut-off. To the best of our 
knowledge, only the study of He and Wharrad
(39)
 described that a score of <60% was 
considered “inadequate knowledge” and a score of >80% was considered “good 
knowledge” based on the Chinese education system. Hence, by defining a priori the 
grading criteria of knowledge of DM, our study findings are less subject to bias in the 
interpretation of scores. This study is also important in that it included both urban and 
non-urban areas. Although this presented a logistical nightmare, we felt that this 
would more accurately reflect the educational needs of the people in the central region 
of Thailand.  
 
We are aware of limitations in this study. The finding that knowledge of DM 
of people in the central region of Thailand was generally fair could have been biased 
by the relatively high proportion of respondents with a bachelor‟s degree or higher. 
This sampling bias occurred in spite of our best effort to recruit respondents from 
various places and at different times. Hence, a truly random sampling strategy should 
be considered for similar projects in the future to confirm our findings. Another 
limitation of our study is that it was conducted only in the central region, thus limiting 
generalizability to other regions of the country. However, the central region is the 
most populated region in Thailand and would at least represent the majority of Thais. 
Again, future studies should consider including other core populations, i.e. the 
Northern Thais, Northeastern Thais and Southern Thais, to verify the robustness of 
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2.5. CONCLUSIONS   
Knowledge of DM among the respondents in the central region of Thailand 
was fair (defined as the mean overall knowledge score of >50% to <80%). Specific 
aspects of knowledge of DM that needed further strengthening and specific groups 
that were suitable for future targeted public education campaigns were identified in 
this study. Such targeted public education programs would conceivably be more cost-
effective than campaigns aimed at the masses.  
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3.1. INTRODUCTION 
Diabetes mellitus (DM) is a major health problem with an alarmingly 
increasing prevalence worldwide.
(88)
 The total number of people with type 2 DM 
(T2DM), which accounts for approximately 90% of all DM cases, is projected to rise 
from an estimated 171 million in 2000 to at least 366 million by 2030.
(86)
 This 
escalating increase is more pronounced in developing countries such as Thailand 
where the prevalence of DM is projected to rise from approximately 1.5 to 2.7 million 
in 2000 and 2030, respectively.
(90)
 Besides the increased morbidity caused by its 
complications, DM is one of the major causes of premature mortality in many 
countries. It accounted for 1.7% of the total global mortality in 2002
(4)
 and was the 
fourth leading cause of death in the same year in Thailand.
(7)
 With the projected 
increase in prevalence, DM and its complications place not only substantial physical, 
mental and social well-being burden on the patients, but also enormous economic 
burden on both the patients and healthcare systems, with these impacts much more 




Due to the contribution of lifestyle factors to the development of T2DM,
(94)
 
primary prevention aimed at healthy population is essential.
(28)
 If people are well 
aware of the detrimental impacts of DM and realize that lifestyle modification could 
delay or even prevent the onset of T2DM, they are likely to be keen to adopt a healthy 
lifestyle. This could contribute to reduced incidence of T2DM. However, in order not 
to over-burden the intended audiences with superfluous information, designing health 
promotion and education materials specifically addressing the knowledge gap would 
be the most cost-effective approach. 
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Generally speaking, people‟s knowledge of DM can be affected by many 
factors such as cultures, attitudes, sociodemographics and cognitive functions.
(33)
 This 
has been illustrated by many previous studies which found different level of people‟s 
DM knowledge in different countries, with conflicting conclusions as to the effects of 
some of these factors on DM knowledge.
(28, 31, 34, 39)
 Hence, even though quite a 
number of studies had been conducted to evaluate knowledge of DM and factors 
associated with DM knowledge in various countries, the results from those studies 
may have limited external validity. This is especially of concern in countries such as 
Thailand with regions with high economic development in the major cities and 
relatively less developed provinces. This is a pertinent concern as intuitively residents 
from a metropolis would be expected to have more exposure to health education 
materials and better access to healthcare professionals. This places health educators in 
a dilemma in formulating health promotion and education materials as it is unclear 
whether substantial knowledge gaps about DM exist between these regions. Without 
this knowledge, it is difficult to design effective materials geared to the targeted 
audiences as well as appropriate training for the health educators themselves. Adding 
complexity to this issue is that, to the best of our knowledge, there is no published 
study exploring whether any knowledge gap exists between the more metropolitan 
and the less developed regions in Thailand.  
 
Therefore, this study was conducted with the primary objective of 
investigating and comparing the level of DM knowledge of the residents in Bangkok, 
the capital of and the largest city in Thailand, and that of the residents in other central 
provinces. The secondary objective was to identify potential factors associated with 
knowledge of DM within Bangkok and in other provinces. We hypothesized that, as 
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Bangkok is the center of education and communication of the country, residents there 
would be expected to have better knowledge of DM compared to those in other 
provinces. In addition, we hypothesized that factors associated with DM knowledge 
would be different between the two groups. The results obtained from this study 
would be useful for specific health planning in Thailand, as well as serving as useful 
references for other countries at similar development status.  
 
3.2. METHODS 
3.2.1. Study design and survey instrument 
This cross-sectional survey was performed in Thailand in mid-2007 at various 
times of the day throughout the week. For Bangkok, fifteen districts were selected 
from among 50 districts with the aim to cover as wide a geographical region of 
Bangkok as possible. For other central provinces group, four provinces, namely 
Nakhon Pathom, Nonthaburi, Pathum Thani and Samut Sakhon were selected. 
Although these provinces are considered neighboring provinces of Bangkok, the 
lifestyle and living conditions of the residents in some sub-districts of these provinces 
are still quite different from Bangkok. In addition, highly urbanized sub-districts and 
those connected to Bangkok were excluded from this study. For details on the 
selection of the study locations, respondent recruitment and survey instrument, please 
refer to the Sections 2.2.1-2.2.3 in Chapter 2.   
 
3.2.2. Statistical analyses  
All data were analyzed using SPSS Statistics 17.0 (SPSS Inc., Chicago, IL, 
US). The Student‟s t-test and the Chi-square test were used to compare characteristics 
of respondents in the two groups (Bangkok vs. other provinces). For income, the 
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value of 15,000 Thai Baht (THB; approximately 441.2 USD) was used as the cut-off 
level because people who earn less than 15,000 THB per month are considered as low 
income group in Thailand.
(99)
 Comparisons of the overall DM knowledge score and 
section scores between the two groups were performed by the Student‟s t-test. The 
effect of individual variables on DM knowledge was assessed by univariate analyses 
using either the Student‟s t-test or the one-way analysis of variance (ANOVA), except 
for age and years of education which were assessed by linear regression analysis. 
Furthermore, three separate multiple linear regression (MLR) models were 
constructed. The first two models were constructed for the Bangkok and the other 
provinces subpopulations, respectively, where we entered all the factors found to be 
associated with knowledge in each group in univariate analyses. These models would 
allow us to evaluate if the factors associated with DM knowledge were similar in both 
groups. The third model was constructed for the entire study population with place of 
residence (Bangkok vs. other provinces) together with other factors associated with 
knowledge derived from the first and second models. The significance level was set at 
5% for all analyses.  
 
3.3. RESULTS 
3.3.1.  Sociodemographics of respondents 
As planned, five hundred respondents were recruited from the capital, 
Bangkok, and another five hundreds from the four central provinces. The participation 
rate was about one in five people approached in Bangkok and one in three people 
approached in other provinces. In both groups, more than 80% of the respondents 
preferred to self-administer the study questionnaire. Sociodemographic characteristics 
of the respondents are presented in Table 3.1.  
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Table 3.1:    Sociodemographic characteristics of the respondents in the Bangkok 






Bangkok Other provinces 
Gender     
Male 211 (42.2) 214 (42.8) 
   0.037 0.848 
Female 289 (57.8) 286 (57.2) 
Age (years)     
Mean (SD) 33.53 (13.47) 34.09 (13.42) 0.663* 0.507 
Years of education      
Mean (SD)  14.53 (4.15) 14.13 (4.02) -1.548* 0.122 
Working status     
Currently working  368 (73.6) 412 (82.4) 
11.282 0.001 
Does not work/Retired 132 (26.4) 88 (17.6) 
Income level (in THB)
†
    
None 118 (23.6) 77 (15.4) 
11.044 0.004 <15,000  250 (50.0) 285 (57.0) 
>15,000 132 (26.4) 138 (27.6) 
Own self having DM    
Yes 17 (3.4) 19 (3.8) 
0.115 0.734 
No 483 (96.6) 481 (96.2) 
Having a family member/relative/friend with DM 
Yes 264 (52.8) 306 (61.2) 
7.197 0.007 
No 236 (47.2) 194 (38.8) 
    
  THB=Thai Baht    
  * Value of „t‟ from the Student's t-test 
†




The respondents in both groups were predominately females. The mean (SD, 
range) age of the respondents was 33.53 (13.47, 15 to 84) years for the Bangkok 
group, and 34.09 (13.42, 15 to 85) years for the other provinces group. There were 
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significant differences between the two groups for working status (p=0.001), income 
level (p=0.004) and having a family member/relative/friend with DM (p=0.007).  
 
3.3.2. DM knowledge score before adjusting for potential confounders 
Before adjusting for potential confounders, respondents from other provinces 
were found to be significantly more knowledgeable than those from Bangkok 
(p=0.029) (Table 3.2). Likewise, the former also had significantly higher mean score 
in the sections of risk factors and symptoms and complications. However, in both 
groups, the respondents performed best in the section of risk factors, followed by 
treatment and management, and monitoring. In a similar manner, general knowledge 
of DM and DM in women were revealed to be areas of knowledge deficiency with 
both groups obtaining scores less than acceptable level.  
 
 
Table 3.2:    Overall DM knowledge scores and scores in each section of the 
respondents in each group 
 
 
Score (maximum score) 
Mean (SD) percentage score* 
p-value 
Bangkok Other provinces 
Overall score (42) 58.21 (20.69) 60.95 (18.95) 0.029 
    
Section score†    
  II.   General knowledge of DM (8) 46.88 (25.75) 48.00 (24.88) 0.463 
III.  Risk factors (4) 70.00 (28.25) 74.00 (27.25) 0.024 
  IV.  Symptoms and complications (11) 55.64 (27.36) 60.27 (26.82) 0.008 
  V.   Treatment and management (11) 69.18 (25.18) 70.64 (22.27) 0.339 
  VI.  Monitoring (5) 68.00 (29.00) 70.40 (28.00) 0.170 
  VII. DM in women (3) 25.33 (31.33) 29.33 (32.33) 0.055 
    
    * Mean percentage score expressed as mean (section) score over maximum (section)    
    score multiplied by 100 (e.g. 24.45/42*100=58.21 and 3.75/8*100=46.88).  
  † 
Section I is the sociodemographic section. 
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3.3.3. Factors associated with knowledge of DM  
In univariate analyses, factors associated with better knowledge of DM in both 
groups were: more years of education; higher income level; own self having DM; and 
having a family member/relative/friend with DM. Older age was found to be a 
significant factor only in the other provinces group (Table 3.3). In MLR analyses 
(Table 3.4), factors that remained statistically significant in the final model for the 
Bangkok group were: more years of education; income >15,000 THB; own self 
having DM; and having a family member/relative/friend with DM. In the final model 
for the other provinces group, older age was another important factor in addition to 
more years of education and having a family member/relative/friend with DM. Hence, 
the factors associated with knowledge of DM in the two groups were not identical. In 
the analysis for the entire study population with place of residence (Bangkok vs. other 
provinces), age, years of education, income level, own self having DM and having a 
family member/relative/friend with DM as independent variables, residing in other 
provinces remained a factor associated with better knowledge on DM.  
 
3.3.4. Responses to open-ended questions 
Major sources of DM information of the respondents in each group are shown 
in Table 3.5. Friends or relatives and various kinds of media were found to be the 
most cited sources in both groups. Only about one-third of the respondents in each 
group informed that they obtained DM information from healthcare professionals. 
With regards to DM organizations and support groups for people with DM in 
Thailand, 11.8% of the respondents in the other provinces group knew that they exist 
while only 7.2% of the respondents in the Bangkok group did. However, in both 
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groups, among those who knew the existence of DM organizations or support groups, 
the majority of them could not specify any name of those organizations.   
 
   
Table 3.3:    Factors associated with DM knowledge of the respondents in each 
group in univariate analyses 
 
 







Gender     




Female 59.04 (20.95) 61.70 (18.47) 
Age      
Coefficient (SE) 0.121 (0.069) 0.077 0.128 (0.063) 0.043 
Years of education;     
Coefficient (SE) 1.235 (0.217) <0.001 1.071 (0.206) <0.001 
Working status     




   Does not work/Retired 56.91 (20.14) 62.01 (16.06) 
Income level (in THB)
 †
     
    None 55.33 (20.11) 
0.005 
61.50 (16.62) 
0.001     <15,000  57.00 (20.90) 58.49 (19.63) 
    >15,000 63.06 (20.11) 65.72 (17.93) 
Own self having DM      




No 57.83 (20.81) 60.57 (19.10) 
Having a family member/relative/friend with DM    




No 53.33 (21.30) 56.00 (19.99) 
 
SE=Standard error; THB=Thai Baht 
*Mean percentage score expressed as mean score over maximum score (42) 
multiplied by 100 (e.g. 23.965/42*100=57.06).   
† 
33.15 THB is approximately equal to 1 USD (data on December 3, 2009). 
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Table 3.4:   Multiple linear regression analyses of factors associated with 
knowledge of DM (separate analyses for residents of Bangkok only, residents of 
other provinces only and combined sample) 
 
Bangkok group Coefficient Standardized 
coefficient 
p-value 
(Constant) 32.869 - <0.001 
Years of education 1.215 0.243 <0.001 
Income <15,000 THB* 4.093 0.099 0.064 
Income >15,000 THB* 5.111 0.109 0.041 
Own self having DM 12.001 0.105 0.016 
Having a family member/ 







    
Other provinces group Coefficient Standardized 
coefficient 
p-value 
(Constant) 34.865 - <0.001 
Age (years)  0.207 0.147 0.005 
Years of education 1.180 0.250 <0.001 
Income <15,000 THB* -2.835 -0.074 0.231 
Income >15,000 THB* -0.808 -0.019 0.776 
Own self having DM 5.079 0.051 0.255 
Having a family member/ 








Combined Sample Coefficient Standardized 
coefficient 
p-value 
(Constant) 31.098 - <0.001 
Residing in other provinces
†
 2.522 0.063 0.035 
Age (years) 0.189 0.128 0.001 
Years of education 1.305 0.268 <0.001 
Income <15,000 THB* 0.522 0.013 0.747 
Income >15,000 THB* 1.167 0.026 0.559 
Own self having DM 6.777 0.064 0.047 
Having a family member/ 







        Dependent variable: Mean percentage score; THB=Thai Baht 
    * 33.15 THB is approximately equal to 1 USD (data on December 3, 2009); 
„No income‟ was the reference group for income level.   
         † The reference group was „Bangkok.‟ 
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Bangkok Other provinces 
Friends/Relatives 315 (63.0) 286 (57.2) 
Books/Magazines/Journals 279 (55.8) 266 (53.2) 
TV/Radio 233 (46.6) 237 (47.4) 
Healthcare professionals 185 (37.0) 173 (34.6) 
Internet 85 (17.0) 49 (9.8) 
Meetings/Seminars 36 (7.2) 27 (5.4) 
Others 15 (3.0) 37 (7.4) 
 





3.4.1. Performance of the respondents in the two groups 
This cross-sectional study conducted in Thailand in mid-2007 showed that 
knowledge of DM among the Thai residents in Bangkok and other central provinces 
was considered acceptable with the mean scores higher than 50% of the overall score 
in both groups. Contrary to what we had expected, respondents in the other provinces 
group were likely to outperform the Bangkok group. Place of residence remained 
associated with DM knowledge score even after adjusting for other potential 
confounders. This finding was quite surprising as intuitively we anticipated that 
residents in the capital would have higher DM knowledge score than those in other 
provinces due to higher literacy rate, information access rate and more information 
sources available.
(101)
 However, a reason that may account for this is, as residents in 
the capital are likely to have a more hectic lifestyle, they possibly pay less attention in 
seeking information about a disease considered of no relevance to them. If so, this 
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serves as an important reminder to researchers and healthcare administrators that we 
should not assume that residents in the capital would have better knowledge of a 
disease than those in economically less developed areas. Furthermore, the findings 
that the deficiency in knowledge of DM for the two groups were in the same areas and 
there was similarity in scores in all the sections implied that similar education 
materials for DM could be utilized in the two groups. 
 
3.4.2. Factors associated with knowledge of DM  
Our finding that factors associated with knowledge of DM were not identical 
for the Bangkok and the other provinces groups was important as it highlighted the 
need for different strategies in different settings. Despite this, sometimes it may not be 
financially or logistically viable to have vastly different strategies. Hence, our final 
model provided information on the important factors to consider when planning DM 
education programs at the national level.  
 
The finding that, in both the capital and the other provinces groups, 
individuals with lower level of education reported poorer DM knowledge is in 
agreement with many other studies conducted both in healthy population and/or 
people with DM.
(28, 29, 31-33, 39, 46)
 Unsurprisingly, having a family member/relative/ 
friend with DM was also found to be associated with better DM knowledge in both 
study groups. Perhaps, more can be done to tap on this group of individuals to help 
spread the message of T2DM prevention. It would also be important and interesting to 
know if this group of individuals is more likely to develop T2DM later in their life 
than those who do not have a family member/relative/friend with DM.  
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It was reassuring that people with DM had better knowledge of the disease, at 
least in the Bangkok group and in the combined sample. The consequences of the 
contrary were unthinkable. Nevertheless, we can never assume that this is always true. 
Hence, this was why we included respondents with DM in our study. In addition, an 
interesting finding that we made was that older respondents were likely to be more 
knowledgeable about DM than younger ones, at least in the other provinces group and 
in the combined sample. This is consistent with the study among the general 
population in Singapore.
(44) 
However, a number of studies reported negative relation 
between age and knowledge of DM in other countries.
(33, 34)
 Could there be a 
geographical or cultural difference at play, in that older Asians are better informed 
than younger Asians while older non-Asians are less informed than younger non-
Asians? This would require further elucidation.  
 
3.4.3. Major sources of DM information 
The finding that friends or relatives was the most often reported source of DM 
information emphasized the need to provide knowledge of DM to both healthy 
population and people with DM as well as to correct any misconceptions about the 
disease in both groups. With proper knowledge about DM, people would help in 
educating others around them about the disease. On the contrary, if they possess any 
misconceptions, they would also possibly disseminate the wrong information to 
others. In addition, the finding that various kinds of mass media were also important 
sources of DM information reinforced the influence of the mass media as an 
important channel for disseminating public health messages.  
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3.4.4. DM organizations and support groups for people with DM 
Another interesting finding in this study was that less than a quarter of 
respondents in both groups knew the existence of DM organizations and support 
groups for people with DM in Thailand. This indicated that DM organizations and 
support groups need to increase their visibility to the public to fulfill their intended 
functions. Again, the lower percentage of respondents who knew the existence of 
those organizations in the Bangkok group reinforced that we could not judge people‟s 
awareness of a disease by their areas of residence. 
  
3.4.5. Study limitations 
We acknowledge several limitations in this study. The first and main 
limitation lies in the convenience sampling method used in respondent recruitment, 
especially together with a low participation rate in both study groups that unavoidably 
resulted in selection bias. Generally speaking, people who are willing to participate in 
a health-related survey are likely those more health-conscious. On top of that is the 
high proportion of respondents in both groups having a bachelor‟s degree or higher 
education although we did our utmost to recruit respondents from various locations 
and at different times. These issues could, at least partially, account for the 
satisfactory knowledge scores of the respondents in our study. Although we realize 
that a true population sampling would contribute to more valid results, we could not 
afford to utilize such a time-consuming and very expensive method. Nevertheless, at 
least, this current study serves as a pilot study for a more comprehensive investigation 
of the Thai public‟s knowledge of DM in the future. Second, a significantly higher 
number of respondents with a family member/relative/friend with DM in the other 
provinces group could be the other potential confounder in this study. However, we 
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tried to control the impact of potential confounders through our MLR process. Third, 
again, due to the time and resource constraints, we had to choose the four provinces 
around Bangkok to be representatives of other provinces in central Thailand. This 
approach could limit somewhat the generalizability of our results. Nevertheless, as 
previously described in the methods section, we tried our best in choosing the sub-
districts that were likely to be fairly representative. To verify our current findings, 
future studies should employ a truly random selection of the study provinces or 
consider the recruitment of residents in all central provinces of Thailand.  
 
3.5. CONCLUSIONS 
In conclusion, respondents in this study were generally well informed about 
DM, with the respondents from other central provinces likely to be more 
knowledgeable than those from Bangkok. We have also identified that, for both study 
groups, individuals of lower education level deserved more attention in DM education 
programs. We have also identified people with a family member/relative/friend who 
had DM to be potentially important advocates in the battle against DM in Thailand.
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4.1. INTRODUCTION 
Diabetes mellitus (DM) is one of the most prevalent chronic diseases in 
Thailand, with an estimated prevalence of approximately 1.5 million sufferers in 
2000,
(90) 
and was ranked as the fourth leading cause of death in Thailand in 2002.
(7)
 
Being a chronic disease that needs constant monitoring and significant lifestyle 
changes as well as restrictive treatment regimens, DM profoundly worsens quality of 
life (QoL) of patients. This has been confirmed by many studies which found patients 
with DM to have significantly poorer QoL compared to the general population.
(102, 103)
 
Hence, in order to optimize outcomes in the management of DM, it is necessary to 
ensure that any treatment modality would not only prevent or delay the occurrence of 
DM complications but at the same time should maintain a reasonable level of QoL of 
the patients. Consequently, many questionnaires have been developed to evaluate 
QoL in patients with DM. 
 
Generally, QoL questionnaires may be categorized broadly into generic and 
disease-specific ones. Compared to generic questionnaires which can be applied 
across a wide variety of diseases, disease-specific questionnaires are likely to be more 
sensitive and relevant to patients of a particular disease.
(60)
 For assessing QoL in 
patients with DM, there are a considerable number of DM-specific QoL 
questionnaires available. However, it should be noted that no single questionnaire 
suits every application and the conclusions of a study could be flawed with the use of 
an inappropriate questionnaire. Therefore, many factors need to be carefully 
considered in selecting a questionnaire, for example, content and psychometric 




 Chapter 4. A Thai version of the ADDQoL-19 questionnaire                  Pongmesa, Tipaporn 
 64  
Furthermore, as most QoL questionnaires have been developed in English, 
cross-cultural adaptation and validation process are required before they could be 
appropriately utilized in non-English speaking populations. This is possibly a reason 
why only few studies have been conducted to evaluate QoL of patients with DM in 
Asia despite it being the region where the majority of patients reside both at present 
and in the foreseeable future. Actually, systematic studies of QoL among patients with 
DM in Asia would contribute to the more holistic and successful management of the 
disease. As such, cultural adaptation of existing DM-specific questionnaires would be 
the most cost-effective approach to achieve this objective.  
 
To the best of our knowledge, while several generic questionnaires are 
available in the Thai language, no DM-specific QoL questionnaire is currently 
available in Thai. Therefore, we aimed to develop a Thai version of such an 
instrument, and in this study the Audit of Diabetes-Dependent Quality of Life 
(ADDQoL-19) was chosen because of its unique characteristics which are highly 
desirable. First, it is an individualized instrument, i.e. it allows respondents to indicate 
the aspects of life deemed to be personally applicable to them and then the aspects 
considered „not applicable‟ to their QoL will not be weighted. Second, respondents 
are asked to rate the importance of each relevant aspect to their QoL. Furthermore, its 
usefulness has been proven in many countries, including Singapore, an Asian 
country,
(68)
 and, based on review studies on QoL measurement in patients with DM, 
the ADDQoL-19 is one of recommended DM-specific QoL questionnaires with good 
psychometric properties and an explicit development process.
(58, 61, 104) 
Therefore, a 
validated Thai version of the ADDQoL-19 would be very useful for assessing QoL in 
patients with DM and the overall management of DM in Thailand.  
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4.2. METHODS 
This study was carried out in two phases. The first phase was the translation 
and cultural adaptation of the UK English version of the ADDQoL-19 into Thai. The 
second phase was the evaluation of the psychometric properties of the developed Thai 
version.    
 
4.2.1. Linguistic validation process 
The License Agreement to use and translate the ADDQoL-19 (Standard UK 
English, rev.1.3.06) into Thai was obtained from the questionnaire developer. The 
linguistic validation process was carried out according to the ADDQoL User 
Guidelines (Bradley C. [Professor Clare Bradley, Health Psychology Research, Royal 
Holloway, University of London, Egham, Surrey, TW20 0EX, UK.]). Detailed reports 
were produced at the end of each step.  
 
4.2.1.1. Forward translation 
  The process began with two independent translations by native Thai-speaking 
pharmacy academics fluent in English and had experience in translating QoL 
questionnaires from English into Thai. The two versions were then reconciled by the 
investigator team and the questionnaire developer to create a harmonized translation.  
 
4.2.1.2. Back translation 
 The reconciled forward translation was back translated into English by two 
professional translators engaged by the questionnaire developer. They were native 
English speakers who were fluent in Thai. After several rounds of discussion, 
reconciliation of the forward and back translations to arrive at the preliminary Thai 
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version was then achieved with input from the four translators, study investigator 
team and questionnaire developer.  
 
4.2.1.3.  Clinician and psychologist review 
 The preliminary Thai version was reviewed independently by a clinician with 
over fifteen years‟ experience in treating DM at Samut Sakhon Hospital, a provincial 
tertiary care hospital, and a psychologist at Srithanya Hospital, a well-known mental 
hospital. The two hospitals were located in central Thailand. The clinician and 
psychologist were required to comment on the accuracy, appropriateness, clarity and 
readability/style of the current translation as well as to consider whether the terms 
used would pose any difficulty to Thai patients with DM. The clinician and the 
psychologist were also asked to provide suggestions for improving the preliminary 
Thai version. After reviewing their comments/suggested revisions, further adaptations 
were made accordingly. 
 
4.2.1.4.  Cognitive debriefing interview 
After further adaptations to the translation, one-to-one cognitive debriefing 
interviews were conducted among ten Thai patients with DM at Samut Sakhon 
Hospital in Thailand during 11-21 August 2008. The interviewees were recruited from 
the hospital‟s Outpatient Counseling Unit. They were aged 18 years or over, be able 
to self-complete Thai questionnaires and selected to be diverse in demographics (i.e. 
age, gender, education level and occupation) and medical status (i.e. type/duration of 
diagnosed DM, number of comorbidities/complications and DM treatment regimen). 
These interviews were approved by the hospital‟s ethics review board. All patients 
were fully informed of the purpose of the study and that the interviews would be 
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voice-recorded. Their written consents to participate in the study were obtained before 
the interviews.  
 
In addition to considering whether the items were difficult to understand, the 
interviewees were required to provide detailed information on their interpretations of 
each term/item (conceptual equivalence) as well as the relevance of each item to them 
(item equivalence). Operational equivalence was also assessed by asking the 
interviewees to self-complete the questionnaire from the beginning and then asked for 
their opinions about the questionnaire format and ease of administration. Feedback 
from the interviewees was discussed with the questionnaire developer and further 
revisions to the preliminary Thai version were made until both the developer and 
study investigator team were satisfied with the quality of the translation.  
 
4.2.1.5.  Final proof-reading 
Final proof-reading of the draft copy was performed by the two forward 
translators and the study investigator team to ensure that no error would appear in the 
translated questionnaire and the questionnaire format was appropriate. The draft copy 
of the questionnaire was further reviewed by the questionnaire developer together 
with all relevant reports. The approved Thai version of the ADDQoL-19 was used in 
the validation study.  
 
4.2.2.   Psychometric evaluation  
 After completing the linguistic validation process, an ethically approved cross-
sectional study was conducted at the General Medicine Outpatient Unit of Samut 
Sakhon Hospital during December 2008 to January 2009. Following the rule of thumb 
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that the recommended sample size of respondents for factor analysis should be five or 
ten times the number of observed variables,
(105)
 95 to 190 respondents would be 
appropriate for the ADDQoL-19. However, to compensate for incomplete and 
unusable data, our target sample size was set at 210. The inclusion criteria for 
respondents were: 1) Thai patients, aged 18 years or above, with either type 1 or type 
2 DM (T1DM or T2DM) as diagnosed by physicians; 2) no obvious incoherence in 
speech and/or thoughts as assessed by the nurses in charge; and 3) able to self-
complete Thai questionnaires. The exclusion criterion was patients with gestational 
DM. Using the outpatient appointment lists, patients fulfilling the inclusion criteria 
were randomly selected using random numbers generated by SPSS Statistics 16.0 
(SPSS Inc., Chicago, IL, US). Consenting patients were asked to complete the Thai 
versions of the ADDQoL-19, the EQ-5D and a sociodemographic questionnaire while 
they were waiting to collect their medications. These questionnaires were used with 
written permission from the developers and copyright holders. All patients were fully 
informed of the study‟s purposes and procedures, and written informed consent was 
obtained from all patients prior to their participation in the study.    
 
4.2.3.  Instruments 
4.2.3.1. The Audit of Diabetes-Dependent Quality of Life (ADDQoL-19)
(106)
 
 The ADDQoL-19 comprises two overview items and nineteen domain-specific 
items that DM might affect. The two overview items are scored individually. The first 
item assesses present QoL in general (range: -3 to +3) while the second item assesses 
DM-dependent QoL (range: -3 to +1). For each of the domain-specific items, 
respondents are asked to provide both impact (range: -3 [greatest negative impact] to 
+1 [positive impact]) and importance (range: 0 [not at all important] to +3 [very 
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important]) ratings. The impact rating is multiplied by the importance rating to 
provide a weighted impact (WI) score, ranging from -9 (maximum negative impact of 
DM) to +3 (maximum positive impact of DM), for each domain. Five of the specific 
domains (i.e. „working life,‟ „holidays,‟ „family life,‟ „close personal relationship‟ and 
„sex life‟) include a preliminary „Yes/No‟ question to determine if the domains are 
applicable to the respondents. The average weighted impact (AWI) score which 
reflects the impact of DM on QoL can be generated by averaging WI scores of all 
applicable domains.  
            
4.2.3.2. The EuroQol 5-Dimensions (EQ-5D)
(107)
 
 The EQ-5D is a standardized, generic, preference-based instrument for 
describing and valuing health. It comprises a descriptive system and a visual analogue 
scale (EQ-VAS). The descriptive system defines health in five dimensions: mobility; 
self-care; usual activities; pain/discomfort; and anxiety/depression. Each dimension is 
graded into three levels of severity (no health problems as level 1, moderate health 
problems as level 2 and extreme health problems as level 3), generating 243 possible 
health states. As recommended by the questionnaire developer, these health states can 
be converted to a single summary score (EQ-5D utility score) using value sets derived 
from the UK time trade-off (UK TTO). For the EQ-VAS, respondents are asked to 
rate perception of their health state which is ranged from 0 (worst imaginable health) 
to 100 (best imaginable health) on a feeling thermometer.  
 
 The EQ-5D was selected as an instrument in this study for the following 
reasons. First, it is the only preference-based health status questionnaire available in 
the Thai language. Second, the reliability and validity of the EQ-5D have been 
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demonstrated in many different clinical and research settings.
(48, 108) 
Third, it is a 
simple instrument that could be completed in only a few minutes; therefore, it would 
not constitute excessive burden to the respondents.   
 
4.2.4.   Statistical analyses 
Data collected in the second phase of the study (psychometric evaluation) 
were analyzed using two programs: SPSS Statistics 17.0 (SPSS Inc., Chicago, IL, US) 
and MPlus 5.2 (Muthén & Muthén, Los Angeles, CA, US). Data were expressed as 
means with standard deviations (SD), unless otherwise indicated. To ascertain the 
usefulness of the „not applicable‟ (N/A) options and the necessity of weighting the 
impact scores, the frequency of utilization of N/A responses as well as the difference 
in the rankings of domains after incorporating impact and importance ratings were 
investigated. 
 
4.2.4.1. Factor structure and reliability analyses 
As the structure of the ADDQoL-19 has been investigated previously,
(106) 
confirmatory factor analysis (CFA) using structural equation modeling (SEM) was 
first performed. The exploratory factor analysis (EFA) using principal components 
analysis (PCA) with varimax rotation would subsequently be performed if the results 
of the CFA were different from expected. Besides using eigenvalues more than 1.0 as 
the selection criteria in EFA, we would also evaluate the outcome of a forced one-
factor solution as the Thai ADDQoL-19 was expected to form only a single construct 
as its original version. Reliability of the Thai ADDQoL-19 was examined by using the 
estimation of internal consistency (Cronbach‟s alpha coefficient). Corrected-item-total 
correlations were also calculated to evaluate the strength of association between each 
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domain and the construct measured. As recommended by the questionnaire developer, 
missing data due to the N/A responses were temporarily recoded as zeros when 
conducting factor structure and reliability analyses to allow data from the maximum 




4.2.4.2. Construct validity analysis using the known-groups approach 
Construct validity of the Thai ADDQoL-19 was assessed by the following a 
priori hypotheses:  
1. Respondents with a low EQ-5D utility score and EQ-VAS score would report low 
present QoL on the ADDQoL-19 (overview item I). 
2. Respondents who reported moderate health problems (level 2) and extreme health 
problems (level 3) on the EQ-5D descriptive system would have worse AWI score 
than respondents who reported no health problems (level 1). 
3. Respondents who were female, elderly, had a longer duration of known DM, had 
at least one DM comorbidity/complication, or required insulin, would have lower 
present QoL (overview item I) and AWI scores on the ADDQoL-19.
(65, 102, 109-111)
 
4. Since AWI scores of the ADDQoL-19 capture the impact of DM on QoL, they 
would be expected to correlate better with the DM-dependent item (overview item II) 
than the generic item (overview item I).  
To test these hypotheses, Student‟s t-test, one-way analysis of variance 
(ANOVA) and Spearman‟s rank correlation test were performed where appropriate. 
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4.3. RESULTS 
4.3.1. Linguistic validation process   
During forward translation, some words/phrases were difficult to translate into 
Thai, e.g. “more specific statements,” “aspect of life,” “close personal relationship,” 
“closest personal relationship,” “physically I could do” and “how much I can do 
physically is.” In order to resolve this problem, we tried to select the most applicable 
Thai terms that could convey the original meaning as suggested in the Concept 
Guidelines in translating the ADDQoL provided by the questionnaire developer. To 
improve readability and comprehension, some words were replaced by other words 
that are more natural and suitable in each context. For example, in the instruction 
statements, the words “now” and “statements” were replaced by “next” and 
“questions,” respectively. Revisions were made to some words to make the items 
more complete, clearer and less confusing. For example, we added “to do things” after 
the word “motivation.” The structure of some items was also adjusted to fit Thai 
grammatical structure in order to make the items more accessible for the respondents. 
Furthermore, several alternatives were proposed for some words/phrases and all of 
them were subjected to further investigations in the next steps.  
 
In addition to semantic issues, we ensured that the translated version was 
conceptually equivalent to the original version. For example, “family” in the original 
English means not only immediate family but also any family members, even more 
distant relatives while “family” in Thai often refers to only immediate family. 
Therefore, “my family” was replaced by “my family and/or relatives” in the Thai 
version. Also, some terms were adapted to suit the Thai context/culture. For example, 
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“partner,” “alcohol” and “sex life” were adapted to “boyfriend/girlfriend,” “liquor” 
and “sexual relationship,” respectively.  
 
During back translation, few discrepancies between the original and the 
reconciled forward translation were found and they were resolved by opinions from 
the third back translator. Minor wording changes were made accordingly. However, 
several words/phrases were still subjected to further investigations in the next steps. 
 
In clinician and psychologist review steps, the clinician and the psychologist 
provided similar general comments that the Thai-version questionnaire was accurately 
translated, easy to understand and suitable for use in Thai patients with DM. Both of 
them agreed with the proposed revisions to some items during the translation steps. 
However, they suggested that several revisions may be considered for several items 
and then further revisions were made as necessary. The clinician also suggested that 
the terms „quality of life‟ and „financial situation‟ should be investigated further 
whether they would be familiar to patients who were elderly and those with low 
education level.  
 
Table 4.1 presents demographic and clinical characteristics of interviewees in 
cognitive debriefing interviews. Their ages ranged from 18 to 67 years with the mean 
(SD) age of 40.40 (16.63) years. The interviewees, even those with primary 
education, were able to self-complete the Thai ADDQoL-19. Questionnaire 
completion times ranged from 14 to 20 minutes (Mean [SD]=16.80 [2.53] minutes).  
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1 57 female 2 married 11 7 years 2 OHAs 5 years yes (2) 
          
2 58 male 2 married 23 6 years 
2 OHAs  
+ insulin 
6 years yes (1) 
          
3 18 male 1 single 14 4 years 1 OHA 
 + insulin 
2 years no 
          
4 22 female 1 single 15 7 years insulin 7 years yes (2) 
          
5 40 male 2 separated 15 1 year and 
3 months 
2 OHAs 
1 year and 3 
months 
no 
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6 30 female 2 married 13 2 years insulin 8 months no  
          
7 37 female 2 married 28 3 years 2 OHAs 3 years no 
          
8 27 male 1 married 15 3 years 2 OHAs  
+ insulin 
3 years yes (1) 
          
9 48 female 2 married 17 20 years 2 OHAs 
 + insulin 
1 and a half 
month 
yes (5) 
          





half a month yes (2) 
 
              OHA=Oral hypoglycemic agent  
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In general, the interviewees reported that, except for a few statements, the 
questionnaire (including instructions, items, scales and response options) was clear, 
comprehensive and easy to understand/complete. All of them agreed that the format 
and length of the questionnaire were appropriate. The interviewees could also 
generally understand all items in the way intended by the questionnaire developer. For 
items with several alternatives, the interviewees‟ preferences were roughly the same. 
In addition, although some interviewees remarked that some domains such as “sexual 
relationship,” “working life” and “physical appearance” were no longer important to 
them as they were quite old, all of them agreed that all domains included in the 
questionnaire were relevant to people with DM in general. With regards to the terms 
“quality of life” and “financial situation,” none of the interviewees encountered any 
problem with these terms even though we were previously concerned that the two 
terms may be too formal and/or difficult for some patients. Nevertheless, questions 
like “Are you currently working, looking for work or would you like to work?” were 
found to be confusing to some interviewees as they thought that there were more than 
one question in one sentence. The interviews took approximately two hours per 
interviewee. Considering all feedbacks derived, the preliminary Thai version was 
further modified as appropriate.  
 
In the final proof-reading step, no typographical and grammar error was found 
while a very slight mis-spelling was detected and fixed. A slight revision to the format 
of several statements was made to improve their comprehensibility. Finally, the 
approval to produce the Thai version of the ADDQoL-19 (Thai for Thailand 22.10.08) 
was granted.  
 
Chapter 4. A Thai version of the ADDQoL-19 questionnaire                  Pongmesa, Tipaporn                                                                 
 77  
4.3.2. Psychometric evaluation  
4.3.2.1. Characteristics of respondents  
As planned, 210 respondents were recruited for the study. Among them, four 
respondents returned blank questionnaires. Three respondents did not complete the 
Thai ADDQoL-19 and EQ-5D while two respondents chose more than one response 
option in almost every item in all study questionnaires. These respondents were 
excluded from data analysis leaving the total number of responses for analysis as 201. 
Demographic and clinical characteristics of the respondents are summarized in Table 
4.2. All of the respondents had T2DM. The majority of them were female, aged 45 
years or over, primary educated or less, and earned an income of less than 15,000 
Thai Baht (THB) per month (approximately 452.5 USD, i.e. low-income group
(99)
). 
Their mean (SD) age was 54.25 (9.83) years (range: 18 to 78 years) and their mean 
(SD) duration of known DM was 6.80 (6.67) years (range: 1 month to 36 years). 
Nearly 90% of the respondents had at least one DM comorbidity/complication. The 
mean (SD) number of total medications per respondent was 6.22 (2.69), ranging from 
1 to 14 medications. Less than a quarter of the respondents required insulin therapy.  
 
In general, the respondents, even those with low education level, were able to 
self-administer the Thai ADDQoL-19 even though some respondents took a long time 
to complete it due to their low reading speed or abnormal eyesight. This finding 
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Table 4.2:     Characteristics of respondents in psychometric evaluation (N=201) 
 
 
Characteristic N % 
   
Gender 
 Male 58 28.9 
 Female 143 71.1 
Age range (years) 
 18-24  3 1.5 
 25-44  29 14.4 
 45-64  148 73.6 
 >65  21 10.5 
Education 
   Primary or less 164 81.6 
   Secondary/Tertiary 37 18.4 
Working status 
   Working 96 47.8 
   Not working/Retired 105 52.2 
Income level (in THB)* 
   None 83 41.3 
   <15,000 97 48.3 
 >15,000 21 10.4 
Marital status 
   Not married 52 25.9 
   Married 149 74.1 
Duration of known DM (years) 
   <5 97 48.2 
   5 to <10  52 25.9 
   >10  52 25.9 
Number of comorbidities/complications 
   None 24 11.9 
   >1 177 88.1 
DM therapy 
   Non insulin-requiring 164 81.6 
   Insulin-requiring 37 18.4 
         
                 THB=Thai Baht 
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4.3.2.2. Distribution of responses to the Thai ADDQoL-19 
The distribution of unweighted impact ratings, importance ratings and WI 
scores of each item of the Thai ADDQoL-19 is shown in Table 4.3. Before weighting 
by importance, DM had the greatest impact on „local or long distance journey‟ (-1.94 
[SD=1.03]) and least impact on „people‟s reaction‟ (-1.17 [SD=1.14]). „Financial 
situation‟ was reported as the most important (2.56, SD=0.76) while „sexual 
relationship‟ was reported as the least important (1.36, SD=1.03) items. All items 
were assigned a zero importance score at least once with „freedom to drink‟ being 
most often considered as unimportant (n=59, 29.4%), followed by „physical 
appearance‟ (n=47, 23.4%) and „people‟s reaction‟ (n=45, 22.4%). The items that 
were least often considered as unimportant were „working life‟ (n=5, 2.5%), „self 
confidence‟ (n=5, 2.5%) and „family life‟ (n=6, 3.0%).  
 
After weighting by importance, the ranks of items changed (range: 1 to 7 
levels), with only two items (i.e. „people‟s reaction‟ and „feelings about the future‟) 
remaining in the same position (Table 4.4). The items with the worst WI score were 
„self-confidence‟ (-5.01 [SD=3.27]), „working life‟ (-4.84 [SD=2.93]) and „living 
conditions‟ (-4.68 [SD=3.33]). Further, the N/A option was utilized in all five items 
that offer this option, with the frequency of utilization ranking from 0.5% („family 
life‟) to 58.2% („sexual relationship‟). For those who selected the N/A option for 
„sexual relationship‟ (n=117), their mean (SD) age was 56.38 (9.28) years and the 
majority of them were females (n=96, 82.1%).  
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Leisure activities (201)  -1.57 (1.06) 1.79 (1.06) -3.01 (2.96) 
Working life (183) 9.0 -1.83 (0.95) 2.55 (0.73) -4.84 (2.93) 
Local or long distance journey (201)  -1.94 (1.03) 1.79 (1.14) -3.98 (3.38) 
Holidays (153) 23.9 -1.69 (1.01) 1.96 (0.96) -3.62 (2.90) 
Do physically (201)  -1.62 (1.04) 2.16 (0.91) -3.73 (3.07) 
Family life (200) 0.5 -1.70 (1.05) 2.52 (0.76) -4.44 (3.20) 
Friendships and social life (201)  -1.53 (1.13) 1.73 (1.05) -3.16 (3.12) 
Close personal relationship (140)  30.3 -1.26 (1.14) 2.17 (0.97) -3.02 (3.24) 
Sexual relationship (84) 58.2 -1.42 (1.15) 1.36 (1.03) -2.52 (2.99) 
Physical appearance (201)  -1.64 (1.11) 1.67 (1.16) -3.23 (3.28) 
Self-confidence (201)  -1.90 (1.01) 2.46 (0.76) -5.01 (3.27) 
Motivation (201)  -1.80 (1.00) 2.14 (0.88) -4.24 (3.15) 
People‟s reaction (201)  -1.17 (1.14) 1.67 (1.14) -2.48 (3.07) 
Feelings about the future (201)  -1.82 (1.08) 2.16 (1.03) -4.52 (3.38) 
Financial situation (201)  -1.52 (1.16) 2.56 (0.76) -4.10 (3.46) 
Living conditions (201)  -1.76 (1.08) 2.47 (0.76) -4.68 (3.33) 
Dependence on others (201)  -1.41 (1.15) 2.35 (0.91) -3.53 (3.37) 
Freedom to eat (201)   -1.72 (1.16) 1.79 (1.14) -3.85 (3.62) 
Freedom to drink (201)   -1.25 (1.19) 1.45 (1.21) -2.62 (3.37) 
N/A=Not applicable; WI=Weighted impact 
* There were five items that included a preliminary „Yes/No‟ question to determine if the items were applicable.  
                                        †
 Possible range of WI score: -9 (maximum negative impact) to +3 (maximum positive impact).  
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Change in order 
of ranking 
Leisure activities  12 16 -4 
Working life 3 2 1 
Local or long distance journey  1 8 -7 
Holidays  9 11 -2 
Do physically  11 10 1 
Family life  8 5 3 
Friendships and social life 13 14 -1 
Close personal relationship  17 15 2 
Sexual relationship  15 18 -3 
Physical appearance  10 13 -3 
Self-confidence  2 1 1 
Motivation  5 6 -1 
People‟s reaction 19 19 0 
Feelings about the future  4 4 0 
Financial situation 14 7 7 
Living conditions  6 3 3 
Dependence on others  16 12 4 
Freedom to eat  7 9 -2 
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4.3.2.3. Factor structure analyses 
4.3.2.3.1. Confirmatory factor analysis (CFA) 
CFA was conducted on the 19-domain-specific WI scores of the Thai 
ADDQoL-19. The Root Mean Square Error of Approximation (RMSEA) of 0.096 
indicated a mediocre fit. However, in the Chi-square test of model fit, the null 
hypothesis of a good fit test was rejected (p<0.001) due to a large Chi-square 
(value=434.659, degrees of freedom=152). Furthermore, the Comparative Fit Index 
(CFI) and Tucker Lewis Index (TLI) were 0.802 and 0.777, respectively. They were a 
bit lower than 0.90, which is the widely applied value representing a good fit for 
incremental fit indices. 
  
 Table 4.5 displays the standardized factor loadings for the Thai ADDQoL-19 
by item. The items with the highest standardized factor loadings included „living 
conditions‟ (0.769), „self-confidence‟ (0.734) and „motivation‟ (0.731) while the 
lowest loading was found in the item „sexual relationship‟ (0.229). From the 
standardized factor loading squared (R
2
), the factor best explained the items „living 
conditions‟ (59.2%), „self-confidence‟ (53.9%) and „motivation‟ (53.5%) while it 
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Table 4.5:     Standardized factor loadings from confirmatory factor analysis of 
the Thai ADDQoL-19 
 
 
Item  Factor loading 
Leisure activities  0.392 
Working life 0.460 
Local or long distance journey  0.467 
Holidays  0.552 
Do physically  0.600 
Family life  0.719 
Friendships and social life 0.632 
Close personal relationship  0.450 
Sexual relationship  0.229 
Physical appearance  0.633 
Self-confidence  0.734 
Motivation  0.731 
People‟s reaction 0.638 
Feelings about the future  0.636 
Financial situation 0.645 
Living conditions  0.769 
Dependence on others  0.520 
Freedom to eat  0.514 
Freedom to drink  0.385 
 
All items were significant at p<0.001, except for „sexual relationship‟ 
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4.3.2.3.2. Exploratory factor analysis (EFA)  
As the results of the CFA were not satisfactory, we proceeded to perform an 
EFA for a better understanding of the underlying factor structure among the Thai 
respondents in this study. Results of the EFA using unforced PCA with varimax 
rotation and forced one-factor analysis are presented in Table 4.6. The unforced PCA 
yielded five factors with eigenvalues greater than 1.0. Most items loaded higher than 
0.40 on factor 1 while only a few items loaded highly on factor 4 („freedom to eat‟ 
and „freedom to drink‟) and factor 5 („close personal relationship‟ and „sexual 
relationship‟). The five-factor solution explained 63.29% of the variance. In the 
forced-one factor solution, all items, except for „sexual relationship,‟ had factor 
loadings exceeding 0.40 and explained 36.90% of the variance. The items with the 
highest factor loadings were „living conditions‟ (0.771), „motivation‟ (0.748) and 
„self-confidence‟ (0.744).  
 
4.3.2.4. Reliability analysis  
Cronbach‟s alpha for the 19-item Thai ADDQoL was 0.900, demonstrating 
very good reliability as expected. Table 4.7 shows Cronbach‟s alpha with each item 
deleted. All items, except for „sexual relationship‟ and „freedom to drink,‟ contributed 
to the overall alpha of the scale, i.e. the overall alpha dropped if any item was deleted 
from the scale. The overall alpha remained unchanged if the item „freedom to drink‟ 
was removed, but it increased from 0.900 to 0.902 if the item „sexual relationship‟ 
was removed. Also, the correlated item-total correlations were higher than 0.30 for all 
items, except for „sexual relationship.‟  
 Chapter 4. A Thai version of the ADDQoL-19 questionnaire                                                                                                                         Pongmesa, Tipaporn                                                               
 85  
 
             Table 4.6:     Unforced principal components analysis with varimax rotation and forced one-factor analysis  
             with N/A items recoded as zeros  
 
Item 
Rotated component matrix 
Forced-one 
factor solution 
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 1 
Leisure activities 0.038 0.147 0.740 0.115 0.072 0.444 
Working life  0.384 -0.083 0.734 0.020 -0.096 0.498 
Local or long distance journey  0.132 0.731 0.224 -0.022 -0.034 0.511 
Holidays  0.169 0.447 0.533 0.016 0.204 0.592 
Do physically  0.203 0.315 0.618 0.281 0.116 0.650 
Family life  0.553 0.317 0.329 0.041 0.271 0.735 
Friendships and social life  0.246 0.756 0.102 0.135 0.262 0.670 
Close personal relationship  0.290 0.131 0.069 0.113 0.694 0.486 
Sexual relationship 0.035 0.039 0.045 -0.034 0.863 0.253 
Physical appearance  0.466 0.271 0.193 0.240 0.254 0.658 
Self-confidence  0.673 0.206 0.294 0.208 0.025 0.744 
Motivation  0.625 0.262 0.285 0.237 0.045 0.748 
People‟s reaction  0.425 0.581 0.117 0.033 0.185 0.665 
Feelings about the future  0.773 0.042 0.021 0.208 0.125 0.649 
Financial situation  0.720 0.220 0.141 0.037 0.006 0.663 
Living conditions  0.770 0.236 0.090 0.148 0.230 0.771 
Dependence on others  0.329 0.543 -0.033 0.417 -0.169 0.558 
Freedom to eat  0.299 0.122 0.087 0.753 0.081 0.552 
Freedom to drink  0.121 -0.001 0.176 0.856 0.022 0.426 
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Leisure activities -63.90 1226.254 0.394 0.312 0.899 
Working life  -62.51 1211.091 0.440 0.382 0.898 
Local or long distance journey  -62.94 1200.621 0.447 0.376 0.898 
Holidays  -64.16 1198.608 0.529 0.430 0.895 
Do physically  -63.18 1180.618 0.599 0.465 0.894 
Family life  -62.49 1159.431 0.672 0.548 0.891 
Friendships and social life  -63.75 1176.028 0.612 0.548 0.893 
Close personal relationship  -64.79 1215.416 0.434 0.360 0.898 
Sexual relationship -65.83 1275.921 0.214 0.276 0.902 
Physical appearance  -63.68 1172.198 0.595 0.429 0.894 
Self-confidence  -61.90 1154.360 0.683 0.573 0.891 
Motivation  -62.67 1159.072 0.689 0.558 0.891 
People‟s reaction  -64.43 1181.057 0.597 0.478 0.894 
Feelings about the future  -62.39 1170.079 0.585 0.534 0.894 
Financial situation  -62.81 1164.447 0.594 0.450 0.894 
Living conditions  -62.23 1145.017 0.711 0.661 0.890 
Dependence on others  -63.38 1189.586 0.498 0.357 0.896 
Freedom to eat  -63.06 1179.141 0.501 0.461 0.897 
Freedom to drink -64.29 1216.546 0.378 0.414 0.900 
Overall Cronbach‟s alpha=0.900 
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4.3.2.5. Known-groups validity analysis  
Only two of four proposed hypotheses were fully fulfilled. First, respondents 
with low EQ-5D utility and EQ-VAS scores reported low present QoL score on the 
Thai ADDQoL-19 as hypothesized (Spearman‟s rank correlation coefficients: 0.328 
and 0.345, respectively, p<0.01 for both) (Table 4.8).  
 
 
Table 4.8:     Spearman’s rank correlation among ADDQoL present QoL, DM-
dependent QoL, AWI, EQ-5D utility and EQ-VAS scores 
 
 





AWI Utility  VAS  
ADDQoL scores 
  Present QoL  1.000 - 0.079 0.328* 0.345* 
  DM-dependent QoL - 1.000 0.448* - - 
  AWI 0.079 0.448* 1.000 - - 
 
EQ-5D scores 
  Utility  0.328* - - 1.000   
  VAS  0.345* - - - 1.000  
 




Second, respondents who reported impaired health (moderate/extreme health 
problems) on the EQ-5D descriptive system were likely to have a worse AWI score 
than those who reported no health problems (-3.77 [SD=1.98] vs. -3.68 [SD= 2.31]). 
However, the difference was not statistically significant (p=0.813).  
 
The third hypothesis was partially fulfilled. Except for the mean AWI score of 
female respondents, which was significantly lower than that for the men (-3.94 
[SD=2.06] vs. -3.32 [SD=1.88], p=0.049), the differences between the present QoL 
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and AWI scores of all the comparison groups were not statistically different as shown 
in Table 4.9.  
 
 
Table 4.9:    Comparison of the ADDQoL present QoL and AWI scores by 
gender, age, duration of known DM, presence of comorbidities/complications 
and type of DM therapy   
 
 
Characteristic Mean (SD) 
present QOL  
p-value Mean (SD) 
AWI score  
p-value 
Gender     
 Male 0.29 (1.20) 0.386 -3.32 (1.88) 0.049* 
 Female 0.45 (1.19)  -3.94 (2.06)  
Age (years)     
 <65 0.44 (1.17) 0.283 -3.74 (2.00) 0.643 
 >65 0.14 (1.35)  -3.96 (2.27)  
Duration of known DM (years)     
 <5  0.60 (1.19) 0.087 -3.71 (2.13) 0.123 
 5 to <10  0.27 (1.07)  -3.41 (1.77)  
 >10  0.19 (1.28)  -4.21 (2.03)  
Presence of comorbidities/complications    
   None 0.58 (0.78) 0.284 -4.00 (2.01) 0.534 
  >1 0.38 (1.24)  -3.73 (2.03)  
DM therapy     
   Non-insulin requiring 0.46 (1.21) 0.166 -3.66 (2.08) 0.099  
   Insulin-requiring 0.16 (1.12)  -4.21 (1.73)  
     




Fourth, as hypothesized, the AWI scores correlated better with the DM-
dependent item than the generic item (Spearman‟s rank correlation coefficients:  
0.448 [p<0.01] and 0.079 [p=0.263], respectively) (Table 4.8).  
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4.4.      DISCUSSION 
Our study reported the first ever attempt to develop a Thai version of the 
ADDQoL-19, a DM-specific QoL instrument that is originally in UK English. During 
the linguistic validation process, extensive efforts were put into every step to ensure 
semantic, conceptual, item and operational equivalences between the Thai ADDQoL-
19 and its original version. Following that, the psychometric properties of the Thai 
ADDQoL-19 were evaluated among 201 patients with DM recruited from a public 
tertiary hospital in central Thailand.  
 
Regarding the distribution of responses, we found that, after weighting by 
importance, DM had the least impact on „people‟s reaction.‟ This finding is in 
agreement with that from most ADDQoL studies.
(68, 106, 112)
 However, our finding that 
„self-confidence‟ was the most affected item differs from the ADDQoL study in 
UK,
(106)
 the English ADDQoL study in Singapore
(68)
 and the Portuguese ADDQoL 
study
 (113)
 that all showed the greatest impact of DM on „freedom to eat.‟  The lesser 
impact of DM on „freedom to eat‟ in our study could be possibly because of low 
monthly incomes of the majority of our respondents. Indeed, some of them expressed 
that, due to their limited budget, they could neither eat as much as they wished nor 
have more options in eating even if they did not have DM. This explanation is further 
supported by the respondents in our study nominating „financial situation‟ as the most 
important item. Interestingly, our finding that „financial situation‟ was the most 
important while „sexual relationship‟ was the least important items is different from 
the result of the English ADDQoL study in Singapore.
(68)
 In that study, „family life‟ 
was reported as the most important while „local or long distance journey‟ was 
reported as the least important items. It is noteworthy that these incongruencies 
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among studies in various settings could be attributed at least partially to the impact of 
culture on patients‟ perception of their health and well-being.  
 
To confirm the necessity for weighting of items according to individual 
importance, rankings of items before and after weighting by importance were 
compared in our study. We found that the ranks of items changed substantially after 
weighting. We also found that all items were assigned a zero importance score at least 
once, while sometimes the impact ratings of the corresponding items were not zero. 
These findings indicate that the impact of some items could be under-/over estimated 
if the impact ratings would not be weighted. In addition to weighting impact ratings, 
the usefulness of a N/A option, which is the other key design feature of the ADDQoL, 
was demonstrated in this study. These findings emphasize the importance of utilizing 
individualized QoL instruments. However, it is noted that the percentages of the N/A 
option reported for the item „sexual relationship‟ in our study (58.2%) is much higher 
than those in the ADDQoL studies in UK (23%) and Singapore (21.1%). This may 
well be due to the fact that sex is a sensitive issue within the Thai society, and then 




To obtain a better understanding of the underlying factor structure among the 
Thai patients in this study, we performed factor analyses on the 19 domain-specific 
WI scores. We found that the results from both CFA and EFA were rather 
unsatisfactory. The results from the CFA suggested that the proposed model fitted the 
data poorly. However, it should be noted that the tests in the CFA have some major 
limitations. For example, the Chi-square test could be influenced by sample size and it 
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is highly possible that even a good fitting model could be rejected. The use of the rule 
of thumb that values of incremental indices (i.e. CFI and TLI) greater than 0.90 
represent an acceptable fit of a model is also highly criticized for its inaccuracy.
(115)
 
Incidentally, since the low standardized factor loading of the item „sexual 
relationship‟ signified that the item correlated poorly with the scale, further 
exploration is required for this item. However, due to the fact that data on CFA of the 
ADDQoL are scarce, a comparison of our findings to other similar studies is 
infeasible.  
 
In the EFA, the results of unforced PCA suggest that most items loaded highly 
together on the first factor although there were several apparent clusters. Additionally, 
the finding that the items „freedom to eat‟ and „freedom to drink‟ had a different 
loading pattern from other items is in congruence with the findings from the English 
ADDQoL study in Singapore
(68)
 and the Malay ADDQoL study.
(112)
 Similar to the 
results from the CFA, the forced-one factor solution revealed that the factor could best 
explain items „living conditions,‟ „self-confidence‟ and „motivation.‟ The low loading 
of the item „sexual relationship‟ is in line with the results from the CFA that this item 
correlated poorly with the overall scale. These findings appear to confirm that the 
item is problematic, thus requiring further investigation on how to deal with it 
appropriately. For this, we may need to re-examine the translation of this item to 
consider if any revision should be performed. However, it is noteworthy that the 
unsatisfactory findings from this item could be partially attributed to the high 
frequency of the N/A option reported for this item. It is possible that the wording 
“sexual relationship” in Thai needs to be revised again to make respondents feel more 
comfortable with the item.  
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While further studies are warranted for its factor structure, the Thai ADDQoL-
19 demonstrated very good internal consistency reliability, with the Cronbach‟s alpha 
of 0.900 that is close to the reported values (range 0.850 to 0.943) of other ADDQoL 
studies.
(68, 106, 112, 113)
 We are aware that the high alpha could be due to a large number 
of items in the ADDQoL-19. The results of reliability analysis suggest that the item 
„sexual relationship‟ detracted from the reliability of the scale. Nevertheless, we 
would not recommend its removal since the effect was only marginal and the 
reliability of the scale was still very high when the item was included. In addition, 
considering the mean impact and importance ratings, this item appears to capture a 
relevant and important aspect of the impact of DM. Actually, a similar problem also 
arose in the Portuguese ADDQoL study,
(113)
 but with the item „worries about the 
future.‟ 
 
Regarding the known-groups validity of the Thai ADDQoL-19, since only two 
of four proposed hypotheses were fully supported in our study, further investigations 
are needed to provide more evidence on the ability of the Thai ADDQoL-19 to 
distinguish between known groups.  
 
We are aware that there were several limitations in our study. First, given the 
fact that our study was of cross-sectional design, an evaluation of the questionnaire‟s 
sensitivity to change over time and test-retest reliability was not feasible. Future 
research should attempt to explore these properties using a longitudinal study design. 
Second, although T1DM patients were included in our cognitive debriefing 
interviews, no respondent in the psychometric evaluation study had T1DM in spite of 
our best effort to recruit both T1DM and T2DM patients. Therefore, to ascertain that 
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our Thai ADDQoL-19 could be applicable to patients in both groups, its psychometric 
properties should also be investigated in patients with T1DM in future studies. Third, 
due to the time and resource constraints, our study population was restricted to only 
those in the central region of Thailand, hence potentially limiting generalizability to 
other regions of the country. Nevertheless, considering their demographic and clinical 
characteristics, it may seem reasonable to deduce that our study population could at 
least represent the majority of patients with DM in Thailand. Nonetheless, to verify 
the robustness of our findings, future studies should consider including other core 
populations, i.e. the Northeastern Thais, Northern Thais and Southern Thais.  
 
Finally, we realize that the validity and reliability of a scale also depend on the 
population to which the scale is administered and different scale properties may be 
found with different groups of respondents. It is also noteworthy that the validation of 
QoL instruments is a continuing process that requires more data over time to improve 
their properties, especially in routine clinical settings.  
 
4.5.      CONCLUSIONS  
The Thai ADDQoL-19 was considered conceptually equivalent to its original 
English version and cultural relevant to Thai patients. The usefulness of its unique 
characteristics and the operational equivalence were also proven in this study. 
Although further investigations are warranted to provide more evidence on its factor 
structure and known-groups validity as well as to assess other psychometric properties 
that have not been performed in this study, the Thai ADDQoL-19 demonstrated very 
good internal consistency reliability and it is deemed to be a promising tool for 
assessing QoL among patients with DM in Thailand.  
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5.1. INTRODUCTION 
Over the past decades, healthcare delivery has gradually shifted from disease-
centric approach to patient-centric approach with a greater emphasis on incorporating 
patients‟ perspective into healthcare decision making. In addition to quality of life 
(QoL), treatment satisfaction is another patient outcome that has received growing 
interest in healthcare research. Treatment satisfaction was defined by Weaver et al. as 
“a recipient‟s rating of or report on salient aspects of the process and the result of his 
or her treatment experience.”(70) An assessment of treatment satisfaction may be 
useful to facilitate professionals‟ decision of a treatment option. Several studies found 
that treatment satisfaction was associated with better glycemic control in patients with 
diabetes mellitus (DM).
(65, 116-118)
 This is possibly because patients who are satisfied 
with their treatments tend to behave in ways that improve their health, for example, to 
have higher adherence.
(70)
 Given the complexity in DM therapy as well as the 
importance of patient self-management, treatment satisfaction could be an important 
predictor of treatment success,
(70)
 and one that is easily measurable.  
 
Although a number of instruments are available for an assessment of treatment 
satisfaction in patients with DM, most of them were developed in English. To the best 
of our knowledge, there has been no published study for a Thai version of a DM-
specific treatment satisfaction questionnaire. Therefore, this present study aimed to 
evaluate the psychometric properties of such a questionnaire among patients with DM 
in Thailand, a developing country facing an imminent DM epidemic.
(89)
 The Diabetes 
Treatment Satisfaction Questionnaire status version (DTSQs)
(119)
 was selected for this 
study as it is applicable to all DM treatment regimens, and not specific to only insulin 
therapies or oral hypoglycemic agents (OHAs). In addition, it is simple and quick to 
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complete, therefore, likely to gain patients‟ acceptance easily. Our study would 
provide information on the validity and reliability of the Thai DTSQs which was 
translated from the original English version using a standardized forward-back 
translation protocol and in close collaboration with the questionnaire developer and 
copyright holder, Clare Bradley, Professor of Health Psychology, Royal Holloway, 
University of London, UK. The results would shed some light on potential challenges 
to culturally adapt the DTSQs in other Asian languages as well as the suitability of 
adapting this type of questionnaire in an Asian clinical environment.   
 
5.2. METHODS 
5.2.1.   Study design and participants 
Thai patients who were 18 years old or over, diagnosed with either type 1 or 
type 2 DM (T2DM), able to self-administer Thai questionnaires and seen at the 
General Medicine Outpatient Unit of Samut Sakhon Hospital in Thailand were invited 
to participate in this ethically approved cross-sectional study during December 2008 
to January 2009. Based on the outpatient appointment lists, eligible patients were 
randomly selected using a random number generated by SPSS Statistics 16.0 (SPSS 
Inc., Chicago, IL, US). They were asked to self-complete the Thai versions of the 
Diabetes Treatment Satisfaction Questionnaire status version (DTSQs), the Audit of 
Diabetes-Dependent Quality of Life (ADDQoL-19) and a sociodemographic 
questionnaire while they were waiting to collect their medications. The participants‟ 
clinical characteristics were retrieved from patient records. All participants were fully 
informed of the study and provided written informed consent before participation.  
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5.2.2. Instruments 
5.2.2.1. DTSQs  
The DTSQs aims to measure patient satisfaction with DM treatment 
regimens.
(119)
 It comprises eight items concerned with the treatment for DM and 
respondents‟ experience on hyper- and hypoglycemia over the past few weeks. The 
Treatment Satisfaction scale total, which ranges from 0 (very dissatisfied) to 36 (very 
satisfied), is produced by summation of scores on items 1 (current treatment in 
general), 4 (convenience), 5 (flexibility), 6 (understanding of DM), 7 
(recommendation to others) and 8 (continuation with treatment). The rating of each 
item ranges from 0 (very dissatisfied) to 6 (very satisfied). The two items related to 
perceived frequency of hyperglycemia (item 2) and hypoglycemia (item 3) are 




The ADDQoL-19 aims to measure the impact of DM on QoL.
(106)
 It comprises 
two overview items assessing general QoL and DM-dependent QoL and subsequent 
19 domain-specific items. For each of the domain-specific items, respondents are 
asked to provide both impact rating (ranging from -3 [greatest negative impact] to +1 
[positive impact]) and importance rating (ranging from 0 [not at all important] to +3 
[very important]). A „not applicable‟ (N/A) option is offered in five of these items. An 
average weighted impact (AWI) score is produced by averaging the products of the 
impact and importance ratings of all applicable domains. The score ranges from -9 
(maximum negative impact) to +3 (maximum positive impact). The Thai version of 
the ADDQoL-19 was used with written permission from the questionnaire developer 
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and copyright holder, Clare Bradley, Professor of Health Psychology, Royal 
Holloway, University of London, UK.  
 
5.2.3. Statistical analyses 
Data were analyzed using SPSS Statistics 17.0 (SPSS Inc., Chicago, IL, US) 
and MPlus 5.2 (Muthén & Muthén, Los Angeles, CA, US). Data were reported as n 
(%), mean (standard deviation, SD) or median (interquartile range, IQR) unless 
otherwise indicated. Descriptive statistics were reported for sociodemographic and 
clinical characteristics of participants as well as DTSQs and ADDQoL-19 scores. 
Ceiling effect (expressed as percent attaining a satisfaction score of >30) was 




5.2.3.1. Factor structure and reliability analyses 
As the factor structure of the DTSQs was known (unidimensional), one-factor 
confirmatory factor analysis (CFA) using structural equation modeling (SEM) with 
maximum likelihood estimation (MLE) in MPlus 5.2 (Muthén & Muthén, Los 
Angeles, CA, US) was performed on the six items that constitute the Treatment 
Satisfaction scale total. As recommended by the questionnaire developer, items 
„perceived frequency of hyperglycemia‟ and „perceived frequency of hypoglycemia‟ 
were excluded from these analyses because they may or may not load with other items 
on the scale.
(119)
 Standardized regression weights (factor loadings) were expected to 
be greater than 0.40 for all items. The tests of model fit included: Chi-square test of 
model fit; Root Mean Square Error of Approximation (RMSEA); Comparative Fit 
Index (CFI); and Tucker Lewis Index (TLI).  
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A post-hoc exploratory factor analysis (EFA) would be performed if the 
results of the CFA were unsatisfactory. The EFA would be based on principal 
components analysis (PCA) with varimax rotation involving all eight items in the 
DTSQs.
(119, 121, 122)
 Besides using eigenvalues greater than 1.0 as the criterion for the 
number of factors extracted in the unforced PCA, a forced one-factor solution would 
be performed on the six Treatment Satisfaction items as they were expected to form 
only a single „Treatment Satisfaction‟ construct.(119) Evaluation of internal consistency 
as a measure of reliability was also performed on the six Treatment Satisfaction items 





5.2.3.2. Construct validity analysis using the known-groups approach 
Construct validity of the Thai DTSQs was assessed by the following a priori 
hypotheses:  
1. Participants who required more medications to control DM and its complications 




2. Participants who reported higher frequency of hypoglycemia on DTSQ item 3 
would have lower ADDQoL AWI score representing worse DM-related QoL. 
3. The Treatment Satisfaction scale total would be positively correlated with the 
satisfaction score of the item „current treatment in general.‟ 
 Correlations of the Treatment Satisfaction scale total with the number of 
medications taken and the score of the item „current treatment in general‟ as well as 
the correlation between the frequency of hypoglycemia and the ADDQoL AWI score 
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were explored using Spearman‟s rank correlation test. Statistical significance level 
was set at p<0.05 for all analyses unless otherwise stated.  
 
5.3. RESULTS 
Two hundred and ten participants were initially enrolled in the study. Among 
them, seven participants left at least one questionnaire blank while two participants 
chose more than one response option in almost every item of the questionnaires. 
These participants were excluded from the analyses and then the total number of 
responses for analysis was 201. The participants‟ sociodemographic and clinical 
characteristics are presented in Table 5.1. All of them had T2DM with the majority 
being female (71.1%), of primary education or less (81.6%), unemployed/retired 
(52.2%) and having a low income status (i.e. had no income or earned less than 
15,000 Thai Baht [THB, approximately 452.5 USD] per month) (89.6%). Their age 
ranged from 18 to 78 years, and the length of time since diagnosis of DM ranged from 
one month to 36 years. The most common comorbidities among participants were 
hypertension (77.1%) and dyslipidemia (55.2%), and approximately 46% of them had 
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              Table 5.1:     Characteristics of participants (N=201)  
 
Characteristic N % 
Age [Mean (SD) years]  54.25 (9.83) 
  
Gender 
Male 58 28.9 
Female 143 71.1 
   
Education level 
   Primary or less 164 81.6 
   Secondary/Tertiary 37 18.4 
   
Working status 
   Working 96 47.8 
   Not working/Retired 105 52.2 
   
Income level (in THB)* 
   None 83 41.3 
   <15,000  97 48.3 
   >15,000 21 10.4 
   
Duration of known DM (years) 
  <5  97 48.3 
  >5  104 51.7 
  Mean (SD)  6.80 (6.67) 
  
Medical problems (as diagnosed) 
    DM only  27 13.4 
    DM + Hypertension 63 31.3 
    DM + Dyslipidemia  19 9.5 
DM + Hypertension + Dyslipidemia 92 45.8 
   
DM therapy 
    OHA only 164 81.6 
    Insulin (either alone or combined) 37 18.4 
   
Number of total medications [Mean (SD)]  6.22 (2.69) 
 
 THB=Thai Baht; OHA=Oral hypoglycemic agent(s) 
 * 33.15 THB is approximately equal to 1 USD (data on December 3, 2009).  
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Figure 5.1 shows the distribution of the participants‟ Treatment Satisfaction 
scale total, which ranged from 14 to 36 with the mean (SD) score of 28.60 (5.53). 
Ceiling effect was observed in almost half (48.8%) of the participants. The 
participants‟ scores of each item in the Thai DTSQs are summarized in Table 5.2. 
Among the six items that formed the Treatment Satisfaction scale total, the highest 
score was for „current treatment in general‟ (mean [SD]=5.38 [1.08]) while the lowest 
score was for „recommendation to others‟ (mean [SD]=4.16 [2.21]).  
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Current treatment in general (DTSQ 1) 5.38 (1.08) 6 (1)  2 to 6 
Perceived frequency of hyperglycemia (DTSQ 2) 1.23 (1.91) 0 (2) 0 to 6 
Perceived frequency of hypoglycemia (DTSQ 3) 0.89 (1.54) 0 (2) 0 to 6 
Convenience (DTSQ 4) 4.95 (1.38) 6 (2) 0 to 6 
Flexibility (DTSQ 5) 4.67 (1.61) 5 (3) 0 to 6 
Understanding of DM (DTSQ 6) 4.20 (1.77) 5 (3) 0 to 6 
Recommendation to others (DTSQ 7) 4.16 (2.21) 5 (3) 0 to 6 
Continuation with treatment (DTSQ 8) 5.24 (1.30) 6 (1) 0 to 6 
    
Treatment Satisfaction scale total* 28.60 (5.53) 29 (8) 14 to 36 
 
IQR=Interquartile range 
* Derived by adding the items 1 and 4 to 8 (the two DM control items were excluded 




5.3.1.   Factor structure and reliability analyses 
For the Chi-square test of model fit, the null hypothesis of a good fit test was 
rejected (p<0.001) due to a large Chi-square (value=33.870; degrees of freedom=9). 
The RMSEA value of 0.117 was slightly higher than 0.10, the typically acceptable cut 
off value for most models.
(105)
 Nevertheless, the values of the two fit indices 
approached 1 (CFI=0.849 and TLI=0.749). From the standardized model results, the 
unconstrained loadings were all statistically significant at 0.01 level. The item 
„continuation with treatment‟ had the highest standardized factor loading (0.691) 
while „understanding of DM‟ and „recommendation to others‟ had loadings less than 
0.40 (0.305 and 0.223, respectively). The standardized factor loading squared (R
2
) 
showed that, while the factor could explain 47.7% of the variance in the item 
„continuation with treatment,‟ it could explain only a small portion of variance in 
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Table 5.3:  Confirmatory factor analysis of the Thai DTSQs (showing 
standardized factor loadings and R
2








     
Current treatment in general  0.596 <0.001 0.355 <0.001 
Convenience  0.532  <0.001 0.283 <0.001 
Flexibility  0.587  <0.001 0.345 <0.001 
Understanding of DM  0.305 <0.001 0.093 0.054 
Recommendation to others  0.223 0.006 0.050 0.170 








As the results of the CFA were unsatisfactory, the PCA was performed on all 
eight items in the Thai DTSQs to provide a better understanding of the underlying 
factor structure. Results of the PCA with varimax rotation and forced-one factor 
analysis are presented in Table 5.4. The unforced PCA yielded three factors with 
eigenvalues greater than 1.0. Items „current treatment in general,‟ „convenience,‟ 
„flexibility‟ and „continuation with treatment‟ loaded together on the first factor while 
„understanding of DM‟ and „recommendation to others‟ loaded highly on the third 
factor. Items „perceived frequency of hyperglycemia‟ and „perceived frequency of 
hypoglycemia‟ loaded highly on a factor from that originally hypothesized. The three-
factor solution explained 59.57% of the variance. In the forced one-factor solution, all 
items, except for „recommendation to others,‟ had factor loadings exceeding 0.40 
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(range 0.420 to 0.761) and explained 37.6% of the variance. The item with the highest 
factor loadings was „continuation with treatment.‟ 
 
 
Table 5.4:  Unforced principal components analysis with varimax rotation 
and forced one-factor analysis of the Thai DTSQs 
 
 




Factor 1 Factor 2 Factor 3 Factor 1 
     
Current treatment in general 0.793 0.013 -0.064 0.694 
Perceived frequency of hyperglycemia  -0.090 0.825 0.052 - 
Perceived frequency of hypoglycemia  0.044 0.746 -0.045 - 
Convenience  0.720 0.119 0.046 0.677 
Flexibility  0.677 -0.173 0.121 0.682 
Understanding of DM  0.118 -0.268 0.733 0.420 
Recommendation to others  0.059 0.301 0.736 0.334 
Continuation with treatment  0.656 -0.061 0.389 0.761 
 
* Unforced PCA was performed on all items in the Thai DTSQs 
† 




With regards to the internal consistency of the Thai DTSQs, the Cronbach‟s 
alpha value of 0.596 was quite low compared to the generally accepted value of 0.70 
for a six-item scale (Table 5.5). Cronbach‟s alpha increased to 0.641 upon deletion of 
the item „recommendation to others‟ and decreased if any other items were deleted. 
However, the corrected item-total correlation indicated that, in addition to 
„recommendation to others,‟ „understanding of DM‟ also correlated poorly with the 
scale overall. If these items were removed concurrently, the alpha would increase 
from 0.596 to 0.687. 
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Table 5.5:     Internal consistency reliability of the Thai DTSQs  
 
 












     
Current treatment in general  23.21  25.179  0.389  0.544 
Convenience  23.65  23.258  0.406 0.525 
Flexibility  23.93  22.285 0.371  0.534 
Understanding of DM  24.40  22.911  0.265  0.583 
Recommendation to others  24.44  21.527  0.201  0.641 
Continuation with treatment  23.35  22.380  0.525  0.486 
     




5.3.2.  Construct validity analysis using the known-groups approach 
Only one of the three proposed hypotheses was supported. As hypothesized, 
the Treatment Satisfaction scale total was positively correlated with the score of the 
item „current treatment in general‟ (Spearman‟s rank correlation coefficient=0.496, 
p<0.001). However, no statistically significant correlation was revealed between the 
number of medications taken and the Treatment Satisfaction scale total (Spearman‟s 
rank correlation coefficient=0.124, p=0.080). Likewise, we found no significant 
correlation between perceived frequency of hypoglycemia and the ADDQoL AWI 
score (Spearman‟s rank correlation coefficient=0.046, p=0.513). 
 
5.4. DISCUSSION 
Similar to previous studies utilizing the DTSQs in other countries,
(119-121)
 the 
Treatment Satisfaction scale total of the participants in our study was shown to have a 
negatively skewed distribution with high ceiling effects, indicating that the majority 
of the participants had high treatment satisfaction. A possible explanation for the 
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ceiling effect could be that participants were worried about the potential impact of 
negative reporting on their relationships with the doctor. Although we assured the 
participants that their responses would not jeopardize their medical care in anyway, 
this assurance may not be sufficient. Incidentally, this finding also implies the need 
for using the DTSQ change version (DTSQc) which was designed to overcome 
ceiling effects in baseline treatment satisfaction, together with the DTSQs in a follow-




In the CFA, all tests of model fit suggested that the proposed one-factor model 
might not fit the data well. One may suspect that the sample size in our study could 
limit the robustness of the CFA. However, based on the rule of thumb of five to ten 
observations per variable,
(105)
 our sample size of 201 should be sufficient for a robust 
CFA involving six items. Furthermore, the unforced PCA on all eight items in the 
DTSQs revealed a three-factor structure with items „understanding of DM‟ and 
„recommendation to others‟ loaded on a separate factor. Previous studies have also 
suggested that the two DM control items should be loaded on a separate factor.
(119, 121, 
122)
 Hence, the results of the CFA and EFA in our study are likely to be robust. The 
results from both the CFA and PCA suggested that „understanding of DM‟ and 
„recommendation to others‟ were likely to be problematic due to their low factor 
loadings. These findings are different from the validation studies of the DTSQs in 
other countries
(119, 121, 122)
 which found that all the six Treatment Satisfaction items 
loaded highly together on a single „Treatment Satisfaction‟ factor.  
 
Given that the Thai DTSQs is not unidimensional, it is probably not too 
surprising that the internal consistency was only moderate. Indeed, the internal 
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consistency was improved when items „recommendation to others‟ and 
„understanding of DM‟ were removed. We noted that the internal consistency was 
good for other versions of the DTSQs in various countries (range: 0.77 to 0.89),
(119, 
121, 122)
 suggesting that further improvement may be needed to increase the internal 
consistency of the Thai DTSQs.    
 
For the construct validity analysis, our finding of no significant correlation 
between the Treatment Satisfaction scale total and the number of medications is 
contrary to the general concept of treatment satisfaction that treatment burden, which 
also includes the number of medications required, is one of the main drivers of 
treatment satisfaction.
(71, 72, 76)
 Nevertheless, one may argue that treatment satisfaction 
is a complex concept that is related to many factors, and hence, our finding could be 
confounded by other independent factors as well as the interrelationships among 
various affecting factors.
(124)
 Likewise, our finding of no significant correlation 
between perceived frequency of hypoglycemia and the ADDQoL AWI score 
contradicts the findings from several studies which found that the number of 
hypoglycemic episodes was negatively correlated with QoL in DM patients.
(110, 125-127)
 
However, this could be at least partially attributed to recall bias as the majority of our 
participants reported that they did not experience hypoglycemia recently. From the 
above-mentioned discussion, the current version of Thai DTSQs would require further 
work to improve its reliability and validity. 
 
Finally, we need to acknowledge some limitations in our study. The first one 
lies in the fact that a cross-sectional design was employed in this study, thus making it 
infeasible to assess test-retest reliability and responsiveness of the questionnaire. 
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Future studies with longitudinal design should be conducted to examine these 
properties. Furthermore, the DTSQs was developed for both T1DM and T2DM 
patients, but none of our participants had T1DM. Hence, a psychometric study may be 
needed to investigate its applicability to patients with T1DM as well. In addition, our 
study included a relatively small number of insulin users, as such, the psychometric 
properties of the Thai DTSQs deserve further evaluation in a larger set of insulin-
requiring patients.  
 
It is good research practice to evaluate the psychometric properties of patient-
reported outcome instruments prior to use, especially when the instruments were 
developed in a different population both culturally and clinically. Nevertheless, some 
researchers do skip this important step for various reasons such as insufficient time 
and resources. Although the findings of this study are largely negative, they should be 
reported so that potential users of the Thai DTSQs are aware of the need to wait for an 
improved version of the questionnaire. Additionally, it is worth noting that 
questionnaire validation is an ongoing process that requires more data over time to 
improve questionnaire properties for use in clinical setting.  
 
5.5. CONCLUSIONS 
This current study is the first to provide information on psychometric 
evaluation process of a Thai version of a DM-specific treatment satisfaction 
questionnaire. In general, more work is required to improve the validity and reliability 
of the Thai DTSQs as, according to our results, the proposed one-factor model and 
known-groups validity of the questionnaire were not supported and its internal 
consistency was only moderate. The improvement may involve rewording or even 
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writing new items, in particular with regards to items „understanding of DM‟ and 
„recommendation to others.‟ 
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6.1. INTRODUCTION 
Diabetes mellitus (DM) with a prevalence rate of 6.7% in 2004,
(24)
 and being 
the fourth leading cause of death accounting for 5% of all causes of death in 2002,
(7)
 
is a major public health concern in Thailand. Given the chronic nature and complexity 
of DM, a comprehensive, multifaceted management approach is the key to its 
successful management. Increasingly, more emphasis has been placed on 
incorporating patient-reported outcomes (PROs) into the assessment, as protecting 
and maintaining quality of life (QoL) is now regarded as an important goal in DM 
care. The improvement in clinical outcomes like fasting plasma glucose (FPG) and 
glycated hemoglobin (HbA1c) is no longer regarded as sufficient.
(48)
 Actually, many 
studies have been conducted to assess QoL in patients with DM, using both generic 
and DM-specific instruments, and generally found patients with DM reported worse 
QoL compared to the general population.
(66)
 Furthermore, despite conflicting results 







 duration of diagnosed DM,
(67)
 requirement of 
insulin
(64-66, 68)
 and presence of complications/comorbidities
(64-66)
 were found to be 
associated with QoL outcomes in patients with DM.  
 
Besides QoL, treatment satisfaction has been gaining much interest as another 
important PRO in DM since it is likely to affect patient compliance, willingness to 
continue treatments and self-management, thus possibly leading to improved clinical 
outcomes.
(74)
 Consequently, there are an increasing number of studies assessing 
treatment satisfaction in patient with DM. Like QoL, it was reported that treatment 
satisfaction could be influenced by many factors including patient characteristics such 








 duration of diagnosed DM,
(128)
 frequency of 
hyperglycemia
(67)




Intuitively, incorporating measures to improve health status, QoL and 
treatment satisfaction into treatment plans should contribute to more effective 
management of DM. However, until now, little is known about these outcomes in 
patients with DM in Thailand. To the best of our knowledge, although many studies 
have been conducted to assess these PROs in Europe and the U.S., only a small 
number of studies on health status and QoL are available in Thailand.
(129, 130)
 
Furthermore, none of those studies included a DM-specific instrument in assessment. 
Likewise, no published study on treatment satisfaction among Thai patients with DM 
is available. Since culture plays an important role in shaping patients‟ perception of 
their health and well-being,
(48)
 generalization of the findings from studies conducted 
in other countries to patients with DM in Thailand could be problematic.  
 
Therefore, we aimed to assess health status, QoL and treatment satisfaction as 
well as factors associated with these PROs among patients with DM in Thailand. To 
the best of our knowledge, this would be the first such study to be performed in 
Thailand. The results would provide insights on the impact of DM and its treatment 
on health status and QoL of patients, including the patients‟ preference of therapy, 
and would be useful for improving quality of care, contributing to treatment success 
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6.2.     METHODS 
6.2.1.  Study participants 
After hospital ethics approval, this cross-sectional study was conducted among 
consenting patients at the General Medicine Outpatient Unit of Samut Sakhon 
Hospital, a tertiary care hospital in central Thailand, from December 2008 to January 
2009. To be eligible for the study, participants had to be Thai patients who were at 
least 18 years of age, had either type 1 or type 2 DM (T1DM or T2DM) as diagnosed 
by physicians, had no obvious incoherence in speech and/or thoughts as assessed by 
the nurses in charge and were able to self-complete Thai questionnaires. They were 
randomly selected from the outpatient appointment lists using a random number 
generator in SPSS Statistics 16.0 (SPSS Inc., Chicago, IL, US).  
 
6.2.2. Instruments  
Participants were asked to self-complete the Thai versions of the EuroQol 5-
Dimensions (EQ-5D),
(107)
 the Audit of Diabetes-Dependent Quality of Life 
(ADDQoL-19),
(106)
 the Diabetes Treatment Satisfaction Questionnaire status version 
(DTSQs)
 (119)
 and a sociodemographic questionnaire while they were waiting to 
collect their medications.    
 
  The EQ-5D is a widely used, standardized generic health status instrument 
that consists of a descriptive system and a visual analogue scale (VAS).
(107)
 The 
descriptive system defines health in the following five dimensions: mobility; self-
care; usual activities; pain/discomfort; and anxiety/depression. Each dimension has 
three levels: no problems (level 1), some problems (level 2) and severe problems 
(level 3), generating 243 possible health states, each of which can be converted to a 
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single summary score (EQ-5D utility score) using value sets derived from either the 
EQ-VAS or the time trade-off (TTO) valuation technique. In this study, the UK TTO 
was used as suggested by the EuroQol Group. The possible values of the EQ-5D 
utility score range from -0.594 to +1, where +1 indicates perfect health, 0 indicates 
death and the values less than 0 indicate health states worse than death. For the EQ-
VAS, respondents are asked to rate their own health state on a vertical VAS, ranging 
from 0 (worst imaginable health) to 100 (best imaginable health). The Thai EQ-5D 
was used with written permission from the developer, the EuroQol group. 
 
 The ADDQoL-19 is an individualized instrument that assesses the impact of 
DM on QoL.
(106)  
It begins with two overview items that assess generic present QoL 
and DM-dependent QoL. These two items are scored individually. For the subsequent 
19 domain-specific items, respondents are asked to provide both impact (ranging from 
-3 [greatest negative impact] to +1 [positive impact]) and importance (ranging from 0 
[not at all important] to 3 [very important]) ratings. The impact rating is multiplied by 
the importance rating to provide a weighted impact (WI) score (ranging from -9 
[maximum negative impact] to +3 [maximum positive impact]) for each item. Five 
domain-specific items include a „not applicable‟ (N/A) option. An average weighted 
impact (AWI) score is generated by averaging the products of the impact and 
importance ratings of all applicable domains. A lower negative AWI score indicates 
better QoL. The Thai ADDQoL-19 was used with written permission from the 
developer and copyright holder. 
 
 The DTSQs is an instrument to measure satisfaction with DM treatment 
regimens.
(119) 
It comprises eight items relating to DM treatment and respondents‟ 
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experience over the past few weeks. A Treatment Satisfaction scale total (ranging 
from 0 [very dissatisfied] to 36 [very satisfied]) is produced by summing up the 
ratings for items 1 and 4 to 8 (ranging from 0 [very dissatisfied] to 6 [very satisfied]). 
The remaining two items measure perceived frequency of hyperglycemia (item 2) and 
perceived frequency of hypoglycemia (item 3). They are analyzed separately on a 
scale ranging from 0 (none of the time) to 6 (most of the time). The Thai DTSQs was 
used with written permission from the developer and copyright holder. 
 
6.2.3. Statistical analyses   
All statistical analyses were performed with SPSS Statistics 17.0 (SPSS Inc., 
Chicago, IL, US). Data are expressed as n (%) or means with standard deviations 
(SD) unless otherwise indicated. Associations between patient characteristics and EQ-
VAS score, EQ-5D utility score, AWI score (from the ADDQoL-19) and Treatment 
Satisfaction scale total (from the DTSQs) were first analyzed by univariate analyses 
and then by multiple linear regression (MLR) analyses. The patient characteristics 
included were: gender, education level, working status, income level, marital status, 
body mass index (BMI) range, number of complications/comorbidities, type of DM 
therapy, age and duration of known DM. In univariate analyses of the scores from the 
EQ-5D and the ADDQoL-19, Pearson‟s correlation analysis was used for the last two 
characteristics as they were treated as continuous variables while Student‟s t-test and 
one-way analysis of variance (ANOVA) were used, where appropriate, for other 
characteristics. Nonparametric tests (Spearman‟s rank correlation test, Mann-Whitney 
U test and Kruskal-Wallis test) were used with the Treatment Satisfaction scale total. 
The characteristics found to be statistically significant in univariate analyses were 
included in MLR analyses where the associations were evaluated while adjusting for 
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potential confounders. The significance level was set at 5% for all analyses unless 
otherwise stated. 
 
For BMI categorization, we adopted the recommended BMI cut-offs for Asian 
populations, that are: <18.5 kg/m
2
 - underweight; 18.5 to <23 kg/m
2
 – normal; 23 to 
<27.5 kg/m
2 
- overweight; and >27.5 kg/m
2
 – obese.(131) For income level, the value of 
15,000 Thai Baht (THB, approximately 452.5 USD) was used as the cut-off in this 
study because people earning an income of less than 15,000 THB per month are 




6.3. RESULTS  
Overall, two hundred and one patients were recruited in this study. All 
participants had type 2 DM and their sociodemographic and clinical characteristics 
are presented in Table 6.1. The majority of them were female (71.1%), aged 45 years 
or over (73.6%), primary educated or less (81.6%) and required only oral 
hypoglycemic agents (OHAs) for DM therapy (81.6%). Almost half (45.8%) had both 
hypertension and dyslipidemia concurrently with DM. The mean scores from the EQ-
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     Table 6.1:     Characteristics of participants (N=201) 
 
 
Characteristic N % 
   
Gender 
Male 58 28.9 
Female 143 71.1 
   
Education 
  Primary or less 164 81.6 
  Secondary/Tertiary 37 18.4 
   
Working status 
  Employed 96 47.8 
  Unemployed/Retired 105 52.2 
   
Income level (in THB)* 
  None 83 41.3 
  <15,000 97 48.3 
>15,000 21 10.4 
   
Marital status 
  Not married 52 25.9 
  Married 149 74.1 
   
BMI
†
 range   
  Underweight/Normal  33  16.4 
  Overweight 93  46.3 
  Obese 75 37.3 
   
Number of complications/comorbidities 
  None 24 11.9 
    1 70 34.8 
  >2 107 53.2 
   
DM therapy 
  Oral therapy only  164 81.6 
  Insulin only or combined 37 18.4 
   
Characteristic Mean (SD)  Range 
Age (years) 54.25 (9.83) 18 to 78 
Duration of known DM (years)   6.80 (6.67) 1 month to 36 years 
   
 
        THB=Thai Baht; BMI=Body mass index 
        * 33.15 THB is approximately equal to 1 USD (data on December 3, 2009) 
 
          † 
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Score (possible score) Mean (SD) Range 
EQ-5D   
  VAS score (0 to 100) 65.22 (17.54) 0 to 100 
  Utility score (-0.594 to +1) 0.74 (0.20) -0.08 to +1 
   
ADDQoL-19   
  Present QoL (-3 to +3) 0.41 (1.19) -3 to +3 
  DM-dependent QoL (-3 to +1) -1.86 (0.93) -3 to 0 
  AWI score
* 
(-9 to +3) -3.76 (2.03) -9 to 0 
   
DTSQs   
  Perceived frequency of  hyperglycemia (0 to 6) 1.23 (1.91) 0 to 6 
  Perceived frequency of hypoglycemia (0 to 6) 0.89 (1.54) 0 to 6 
  Treatment Satisfaction scale total
†
 (0 to 36) 28.60 (5.53) 14 to 36 
       
VAS=Visual analogue scale; AWI=Average weighted impact 
      * Generated by averaging the products of the impact and importance ratings of all  
      applicable domains
 
         † Computed by adding items 1 and 4 to 8 (items „perceived frequency of  
      hyperglycemia‟ and „perceived frequency of hypoglycemia‟ were excluded) 
   
 
 
6.3.1. EQ-5D scores 
 Around 15% of the participants (n=30) reported perfect health (i.e. they 
reported level 1 for all five dimensions). Among the five dimensions, the proportion 
of participants reporting any problems was highest (61.2%) in „pain/discomfort‟ and 
lowest (4.0%) in „self-care.‟ Percentages of participants reporting severe problems 
were relatively low for all dimensions (ranging from 0.5 to 3.5%) (Figure 6.1). The 
mean (SD) of the participants‟ EQ-VAS and EQ-5D utility scores were 65.22 (17.54) 
and 0.74 (0.20), respectively (Table 6.2). Univariate analyses revealed that 
participants with higher education and income level were likely to report significantly 
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higher EQ-5D scores (Table 6.3); however, only income level remained significant in 
MLR analyses (Table 6.4). In addition, it is noted that, while a significant difference 
in the EQ-VAS score was observed between participants with no income and those in 
both higher income levels (<15,000 and >15,000 THB, approximately 452.5 USD), 
significant difference was found only between participants with no income and those 













% of participants 
Figure 6.1:     The participants’ reported health status by dimension as measured 
by the Thai EQ-5D 
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6.3.2. ADDQoL scores 
The majority of the participants reported „good‟ (n=80, 39.8%) or „neither 
good nor bad‟ (n=63, 31.3%) for their present QoL. Only 16% of them (n=32) 
reported negative (bad, very bad or extremely bad) present QoL. Regarding DM-
dependent QoL, as high as 91% of the participants (n=183) reported a negative impact 
of DM on their QoL, and none of them felt that DM had a positive impact on their 
QoL. Among nineteen domains included in the ADDQoL, „financial situation,‟ 
„working life‟ and „family life‟ were rated as the most important domains with the 
mean (SD) importance ratings of 2.56 (0.76), 2.55 (0.73) and 2.52 (0.76), respectively 
while „sexual relationship‟ was rated as the least important one (1.36, SD=1.03). 
Before weighting, the domains with the worst impact by DM were „local or long 
distance journey‟ (-1.94, SD=1.03), „self-confidence‟ (-1.90, SD=1.01) and „working 
life‟ (-1.83, SD=0.95) while the domain with the least impact was „people‟s reaction‟ 
(-1.17, SD=1.14). After weighting by importance, the domains most and least affected 
by DM were „self-confidence‟ (-5.01, SD=3.27) and „people‟s reaction‟ (-2.48, 
SD=3.07), respectively (Table 6.5). The negative value of the mean AWI score (-3.76, 
SD=2.03) indicated a negative impact of DM on the participants‟ QoL. In univariate 
analyses, women, those with primary or less education and those who were 
unemployed/retired had significantly lower AWI scores than other participants (Table 
6.3). However, only education level and working status remained statistically 
significant in MLR analyses (Table 6.4).  
 
6.3.3. DTSQs scores 
The majority of the participants reported that they did not have unacceptably 
high or low blood sugar levels during the past few weeks before the study (n=128 
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[63.7%] and 138 [68.7%], respectively). From the maximum possible score of 36, the 
mean Treatment Satisfaction scale total of the participants was 28.60 (SD=5.53) 
(Table 6.2). At Ceiling Treatment Satisfaction scale total, defined as the score 
>30,
(120)
 was reported by as high as 48.8% of the participants (n=98).  Among the six 
treatment satisfaction items, the highest mean satisfaction score was for „current 
treatment in general‟ (DTSQ1) (5.38, SD=1.08), whereas the item with the lowest 
satisfaction score was „recommendation to others‟ (DTSQ7) (4.16, SD=2.21) (Table 
6.6). Female gender and older age were found to be associated with higher treatment 






Chapter 6. Health status, QoL and satisfaction in DM                                                                                                                                       Pongmesa, Tipaporn  
124 
            Table 6.3: EQ-VAS score, EQ-5D utility score, AWI score (from the ADDQoL-19) and Treatment Satisfaction scale total 
            (from the DTSQs) according to patient characteristics in univariate analyses  
 
 
Characteristic EQ-VAS score EQ-5D utility score AWI score Treatment Satisfaction 
scale total  
Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value 
Gender         
   Male 62.93 (17.37) 0.239 0.73 (0.23) 0.634 -3.32 (1.88) 0.049 27.26 (5.46) 0.020 
   Female 66.15 (17.58)  0.74 (0.18)  -3.94 (2.06)  29.14 (5.48)  
Education          
   Primary or less 63.96 (17.68) 0.032 0.72 (0.20) 0.017 -3.95 (2.05) 0.006 28.85 (5.42) 0.202 
   Secondary/Tertiary 70.81 (15.92)  0.81 (0.14)  -2.94 (1.69)  27.49 (5.93)  
Working status         
   Employed 67.50 (15.91) 0.078 0.74 (0.20) 0.708 -3.34 (2.05) 0.005 27.90 (5.52) 0.054 
   Unemployed/Retired 63.14 (18.74)  0.73 (0.20)  -4.15 (1.94)  29.24 (5.48)  
Income level (in THB)*        
   None 61.21 (18.26) 0.007 0.69 (0.21) 0.012 -4.05 (2.10) 0.101 28.70 (5.76) 0.833 
   <15,000 66.91 (17.19)  0.76 (0.18)  -3.68 (1.96)  28.40 (5.52)  
   >15,000 73.33 (11.87)  0.82 (0.14)  -3.02 (1.93)  29.10 (4.76)  
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Table 6.3:     EQ-VAS score, EQ-5D utility score, AWI score (from the ADDQoL-19) and Treatment Satisfaction scale total 
(from the DTSQs) according to patient characteristics in univariate analyses (continued) 
  
Characteristic EQ-VAS score EQ-5D utility score AWI score Treatment Satisfaction 
scale total 
Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value 
Marital status         
   Not married 62.12 (18.87) 0.138 0.73 (0.24) 0.861 -3.79 (2.13) 0.911 28.29 (6.23) 0.997 
   Married 66.31 (16.98)  0.74 (0.18)  -3.75 (2.00)  28.70 (5.28)  
BMI
†
 range         
  Underweight/Normal 64.24 (15.92) 0.911 0.75 (0.14) 0.739 -3.96 (2.01) 0.722 28.67 (4.29)  
0.779   Overweight 65.11 (18.36) 0.73 (0.21) -3.79 (2.05) 28.54 (5.30) 
  Obese 65.80 (17.38) 0.75 (0.19) -3.63 (2.02) 28.64 (6.30) 
Number of complications/comorbidities 
   None 67.92 (16.93) 0.710 0.77 (0.19) 0.544 -4.00 (2.01) 0.817 26.50 (6.15) 0.137 
     1 65.21 (19.49)  0.72 (0.24)  -3.75 (2.14)  28.73 (5.29)  
   >2 64.63 (16.39)  0.74 (0.17)  -3.71 (1.97)  28.98 (5.50)  
DM therapy         
  Oral therapy only  65.31 (18.09) 0.891 0.74 (0.20) 0.736 -3.66 (2.08) 0.099 28.90 (5.41) 0.121 
  Insulin only/combined 64.87 (15.07)  0.73 (0.17)  -4.21 (1.73)  27.27 (5.92)  




Table 6.3:     EQ-VAS score, EQ-5D utility score, AWI score (from the ADDQoL-19) and Treatment Satisfaction scale total 
(from the DTSQs) according to patient characteristics in univariate analyses (continued) 
 
 
Characteristic EQ-VAS score EQ-5D utility score AWI score Treatment Satisfaction 
scale total 
Correlation p-value Correlation p-value Correlation p-value Correlation p-value 
Age (years) -0.107 0.132 -0.104 0.140 -0.056 0.431 0.175 0.013 
Duration of known DM (years) -0.123 0.082 -0.054 0.446 -0.130 0.067 0.042 0.554 
 
      THB=Thai Baht; BMI=Body mass index 
      * 33.15 THB is approximately equal to 1 USD (data on December 3, 2009) 
         † 








      Table 6.4:   Associations between patient characteristics and EQ-VAS score, EQ-5D utility score, AWI score (from the ADDQoL-19)  




EQ-VAS score EQ-5D utility score AWI score Treatment Satisfaction 
scale total 
Coefficient p-value Coefficient p-value Coefficient p-value Coefficient p-value 
Male gender     0.286 0.374 -1.850 0.030 
Age (years)       0.079 0.043 
Secondary/Tertiary education 3.987 0.262 0.060 0.132 0.846 0.022   
Employed     0.669 0.021   
Income level (in THB)*         
<15,000  5.511 0.034 0.060 0.036     
>15,000 9.665 0.043 0.089 0.095     
 
Reference groups: female (for the variable „gender‟), primary education or less (for the variable „education‟), unemployed/retired (for the 
variable „working status‟) and no income (for the variable „income level‟)  
THB=Thai Baht 
* 33.15 THB is approximately equal to 1 USD (data on December 3, 2009).  
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     Table 6.5:     Impact of DM on the QoL domains in the Thai ADDQoL-19  
 
 
QoL domain Mean (SD) score  Range 
   
    Self-confidence  -5.01 (3.27) -9 to 0 
    Working life* -4.84 (2.93) -9 to 0 
    Living conditions  -4.68 (3.33) -9 to 0 
    Feelings about the future  -4.52 (3.38) -9 to 0 
    Family life* -4.44 (3.20) -9 to 0 
    Motivation  -4.24 (3.15) -9 to 0 
    Financial situation  -4.10 (3.46) -9 to 0 
    Local or long distance journey  -3.98 (3.38) -9 to 0 
    Freedom to eat  -3.85 (3.62) -9 to +1 
    Do physically  -3.73 (3.07) -9 to 0 
    Holidays* -3.62 (2.90) -9 to 0 
    Dependence on others  -3.53 (3.37) -9 to 0 
    Physical appearance  -3.23 (3.28) -9 to 0 
    Friendships and social life  -3.16 (3.12) -9 to 0 
    Close personal relationship* -3.02 (3.24) -9 to 0 
    Leisure activities  -3.01 (2.96) -9 to +2 
    Freedom to drink  -2.62 (3.37) -9 to +3 
    Sexual relationship* -2.52 (2.99) -9 to 0 
    People‟s reaction  -2.48 (3.07) -9 to 0 
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Table 6.6: Satisfaction with each aspect of DM treatment of participants as 
measured by the Thai DTSQs  
 
 
Aspect of DM treatment Mean (SD) score  Range 
   
Current treatment in general  5.38 (1.08) 2 to 6 
Convenience  4.95 (1.38) 0 to 6 
Flexibility  4.67 (1.61) 0 to 6 
Understanding of DM 4.20 (1.77) 0 to 6 
Recommendation to others  4.16 (2.21) 0 to 6 





6.4.1. Health status, QoL and treatment satisfaction outcomes 
This current study is the first to concurrently assess health status, QoL and 
treatment satisfaction in Thai patients with DM using both generic and DM-specific 
instruments. Overall, our participants reported good health status, poor QoL and high 
treatment satisfaction. In this study, a relatively small proportion of the participants 
reported severe problems on the EQ-5D. Hence, it is not surprising that the mean (SD) 
EQ-5D utility score of 0.74 (0.20) and EQ-VAS score of 65.22 (17.54) were only 
slightly lower than those of the general population aged 55-64 years in UK (0.80, 
SD=0.26 and 79.74, SD=18.23, respectively).
(132)
 This observation was also reported 
in a similar study in the Netherlands.
(65)
 This may imply that if the EQ-5D was used 
as a single instrument to assess PROs in patients with DM, the impact of DM would 
likely be underestimated.  
 
Given the mean AWI score (from the ADDQoL-19) of -3.76 (SD=2.03), it 
seems reasonable to conclude that DM had a substantial negative impact on the 
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participants‟ QoL. This is similar to findings from other studies using the same 
instrument with reported AWI scores ranging from -1.95 to -2.50.
(64, 133, 134)
 Our 
finding that „self-confidence‟ was the domain of life most affected by DM differs 
from previous studies using the ADDQoL,
(68, 106, 113)
 where „freedom to eat‟ was 
reported as the most affected domain. However, our finding that DM had the least 
impact on „people‟s reaction‟ is in agreement with several previous studies.(68, 106, 112) 
The finding that the highest satisfaction score was for „current treatment in general‟ is 




6.4.2. Factors associated with health status, QoL and treatment satisfaction 







duration of known DM,
(67)
 presence of complications/comorbidities
(64-66)
 and insulin 
therapy
(64-66, 68) 
were factors associated with health status/QoL in patients with DM, no 
significant association was revealed between these factors and the scores from either 
the EQ-5D or the ADDQoL-19 in our study after adjusting for potential confounders. 
Nevertheless, it is noteworthy that the results from those studies were also mixed, that 
is, while they found significant associations between health status/QoL and some 
factors, no association was found for other factors. These incongruencies among 
studies in different settings could be attributed at least partially to a cultural impact on 
people‟s perception of health and QoL, thus underlining the necessity of local studies. 
Furthermore, the findings from our study would support that sociodemographic 
factors, like education level, working status and income level, should be taken into 
account when planning DM care plan for individual patients.  
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With regards to treatment satisfaction, the positive association between female 
gender and treatment satisfaction in our study is in contrast to a previous study in 
Italy
(128)
 that reported a negative association and another study in the Netherlands
(65)
 
that reported no association between these two variables. In this respect, the studies 
are producing different findings. Our study yielded results consistent with several 
previous studies that neither insulin therapy nor presence of complications/ 
comorbidities was correlated with treatment satisfaction.
(65, 67, 128)
 Likewise, the 
finding that older age was associated with higher treatment satisfaction is in line with 




6.4.3. Study limitations  
We are aware of several limitations in our study. First, given the fact that our 
study was conducted in a public hospital where patients can receive their treatment 
free of charge or pay only a nominal sum, our results might not apply to patients seen 
in private healthcare settings which require a much larger financial outlays from the 
patients. Therefore, to test the robustness of our results, future studies should consider 
assessing health status, QoL and treatment satisfaction in DM patients in different 
healthcare settings. Second, no patient in this study had T1DM. Given the possibility 
that factors associated with health status, QoL and treatment satisfaction may be 
different between people with T1DM and T2DM, a similar study should be conducted 
in those with T1DM. Last, the Thai versions of the ADDQoL-19 and the DTSQs used 
in this study are works in progress, and hence our findings on QoL and satisfaction 
with treatment are subjected to the limitations of the two instruments.  
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6.5. CONCLUSIONS 
DM was found to have little effect on our patients‟ perceived health status but 
major negative impact on their QoL. The health status problem most commonly 
reported was „pain/discomfort‟ while the QoL domain most affected was „self-
confidence.‟ However, the patients‟ satisfaction with their DM treatment was rather 
high, especially for satisfaction with current treatment in general. Several 
demographic characteristics were significantly associated with the patients‟ health 
status, QoL and treatment satisfaction, and these factors were found to be different for 
each outcome. While lower income level was likely to affect health status negatively, 
lower education level and unemployment status were found to adversely affect QoL, 
but female gender and older age were associated with higher treatment satisfaction. 
The results of this study would assist health professionals to understand patients‟ own 
perspective on the impact of DM on each aspect of their life and may facilitate 
patient-physician decision making on appropriate treatments. A better understanding 
of factors associated with each outcome would contribute to the planning and 
development of interventions/health services that are more patient-centered and 
personalized to the patients‟ need and thereby possibly improve overall patient 
outcomes.   
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7.1.     INTRODUCTION 
Type 2 diabetes mellitus (T2DM) is a complex, chronic disease that often 
requires combination therapy overtime for optimal glycemic control. On top of this, 
patients with T2DM are likely to suffer from many T2DM-related complications or 
having comorbidities, particularly hypertension, dyslipidemia and heart diseases, each 
of which commonly requires medication therapy as well. For both T2DM and these 
comorbidities, monotherapy is often inadequate at maintaining adequate control for 
the majority of patients.
(15, 135, 136)
 Hence, polypharmacy, defined as “the use of 
multiple medications by a single patient,”(135) is often inevitable in the management of 
T2DM. 
(15, 135, 136) 
Furthermore, due to recent advances in pharmacological therapies 
as well as favorable results of tight glycemic control on long-term T2DM outcomes 
provided from several recently published large clinical trials,
(137-140)
 it is likely that the 





Although polypharmacy is necessary and beneficial for some T2DM patients, 
it may be inappropriate in some situations and places further economic burden on 
healthcare systems.
(136, 142) 
Moreover, the practice of polypharmacy is more likely to 
lead to various drug-related problems (DRPs). The major ones are drug interactions 
and adverse drug reactions (ADRs), which are among the leading causes of 
hospitalization, especially in the elderly.
(136, 141-146)
 A number of studies found that 
incidences of drug interactions and ADRs in patients with T2DM were significantly 
associated with the numbers of medications taken.
(144, 145)
 The potential of non-
adherence, a common problem in T2DM patients,
(147)
 is another concern with 
polypharmacy. Theoretically speaking, patient adherence to prescribed regimen is 
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crucial for therapeutic success in the management of T2DM. In addition, maintaining 
and protecting patients‟ quality of life (QoL) is regarded as an important goal in 
T2DM management in the new healthcare practice paradigm. From the clinical 
perspective, incorporating QoL assessment in the overall management of T2DM is 
particularly pertinent as treatment regimens could potentially impact QoL of patients. 
Indeed, some previous studies did report that polypharmacy negatively impacted the 
patients‟ QoL.(136, 148, 149)  
 
Based on the principal-agent relationship between patients and healthcare 
providers, the latter is responsible for assuring that medications are prescribed 
appropriately considering necessity and potential impact of those medications on 
various aspects of T2DM management. However, while progress has been made in 
evaluating the impact of medication use, including polypharmacy, on both clinical 
and humanistic outcomes of patients with T2DM in many countries, limited 
information on this issue is currently available in Thailand. The patterns of 
medication use (all-kind and DM-specific) among Thai patients with T2DM have not 
been well established. Furthermore, to the best of our knowledge, there has been no 
published study on the association between polypharmacy and QoL in Thai patients 
with T2DM. This paucity of information and knowledge could hamper the effective 
management of T2DM in Thailand. Therefore, the aims of this study were as follows: 
(1) to describe the prevalence of polypharmacy among T2DM patients in Thailand; 
and (2) to evaluate the association between polypharmacy and QoL. Our study may 
lay the foundation for enhancing the quality of T2DM care and improving patient 
outcomes. A better understanding on the prevalence and consequences of 
polypharmacy might be useful for health professionals in formulating effective 
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medication use strategies for patients with T2DM in Thailand. This information may 




7.2.1. Study design and participants  
After hospital ethics approval, consenting Thai patients with T2DM were 
recruited from the General Medicine Outpatient Unit of Samut Sakhon Hospital 
during December 2008 to January 2009. This hospital is the largest tertiary public 
hospital in Samut Sakhon, a province in central Thailand. The participants were aged 
18 years or above and had received at least one DM medication during the past three 
months. They were randomly selected from the outpatient appointment lists using the 
random numbers generated by SPSS Statistics 16.0 (SPSS Inc., Chicago, IL, US). The 
participants self-completed the Thai versions of the Audit of Diabetes-Dependent 
Quality of Life (ADDQoL-19) and a sociodemographic questionnaire. Following that, 
they were interviewed about the medications they had taken during the past three 
months. The list of medications they received at the last visit was also reviewed to 
ensure completeness of information. The participants‟ clinical data were retrieved 
from patient records.  
 
7.2.2. Study instrument  
  The ADDQoL-19 is an individualized DM-specific QoL instrument.
(106)
 It 
comprises two overview items and nineteen domain-specific items that DM might 
affect. The two overview items assessing generic present QoL and DM-dependent 
QoL are scored individually. The nineteen domain-specific items ask the respondents 
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to indicate both the impact of DM on the domains (range: -3 [greatest negative 
impact] to +1 [positive impact]) and the importance of those domains to their QoL 
(range: 0 [not at all important] to 3 [very important]). The impact rating is multiplied 
by the importance rating to provide a weighted impact (WI) scores for each domain 
(range: -9 [maximum negative impact] to +3 [maximum positive impact]). Among the 
domain-specific items, five of them include a „not applicable‟ (N/A) option. An 
average weighted impact (AWI) score is derived by averaging WI scores of all 
applicable domains. The Thai ADDQoL-19 was used with written permission from 
the developer and copyright holder.  
 
7.2.3. Definitions 
Body mass index (BMI) 
 We adopted the recommended BMI cut-off points for Asian populations, that 
are: (1) less than 18.5 kg/m
2
 - underweight; (2) 18.5 to less than 23 kg/m
2
 – normal; 
(3) 23 to less than 27.5 kg/m
2 
- overweight; and (4) 27.5 kg/m
2
 and over – obese.(131) 
Polypharmacy 
 In this study, polypharmacy was defined as the concurrent use of five or more 
different medications.
(141, 142, 146)  
One of the medications must be DM medication. 
 
7.2.4.   Statistical analyses 
 Data are expressed as n (%) or means with standard deviations (SD) unless 
otherwise indicated. Student‟s t-test and one-way analysis of variance (ANOVA) 
were used, where appropriate, to assess the following associations: (1) participants‟ 
characteristics and numbers of all-kind medications/DM medications; and (2) 
polypharmacy and QoL (generic present QoL, DM-dependent QoL and AWI scores). 
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The associations found to be significant in univariate analyses were further assessed 
in multiple linear regression (MLR) analyses where potential confounders were 
adjusted. All statistical analyses were performed with SPSS Statistics 17.0 (SPSS Inc., 
Chicago, IL, US) and the significance level was set at 5%.  
 
7.3.  RESULTS 
 A total of 199 patients with T2DM were recruited in this study. Their 
characteristics are presented in Table 7.1. The participants‟ mean age was 54.28 
(SD=9.88, range 18 to 78) years and approximately 86% of them had comorbid 
hypertension and/or dyslipidemia.  
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Number of all-kind medications  Number of DM medications  
Mean (SD) Range 
p-value 
Mean (SD) Range 
p-value 
Univariate Multivariate Univariate Multivariate 
Gender                   
  Male 57 (28.6) 5.58 (2.85) 1-14 
0.029 0.093 
1.72 (0.62) 1-3 
0.002 0.004 
  Female 142 (71.4) 6.50 (2.59) 2-13 2.03 (0.65) 1-4 
Age (years)          
  18-44 32 (16.1) 3.88 (1.88) 1-7 
<0.001 
- 2.00 (0.72) 1-4 
0.008 
- 
  45-64 146 (73.4) 6.53 (2.44) 1-13 0.016 1.99 (0.63) 1-4 0.260 
  >65 21 (10.5) 7.76 (3.35) 3-14 0.001 1.52 (0.60) 1-3 0.001 
Education level          
  Primary or less 162 (81.4) 6.30 (2.65) 1-13 
0.512 - 
1.93 (0.67) 1-4 
0.537 - 
  Secondary/Tertiary 37 (18.6) 5.97 (2.90) 1-14 2.00 (0.62) 1-3 
Working status            
  Unemployed/Retired 105 (52.8) 6.63 (2.75) 1-14 
0.030 0.838 
1.89 (0.67) 1-4 
0.221 - 
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Table 7.1: Numbers of medications used according to participant characteristics (N=199) (continued) 
 
Characteristic N (%) 
Number of all-kind medications Number of DM medications 
Mean (SD) Range 
p-value 
Mean (SD) Range 
p-value 
Univariate Multivariate Univariate Multivariate 
Marital status          
  Not married 51 (25.6) 6.33 (2.83) 1-14 
0.766 - 
1.92 (0.74) 1-4 
0.820 - 
  Married 148 (74.4) 6.20 (2.66) 1-13 1.95 (0.63) 1-4 
Smoking          
  No 178 (89.4) 6.35 (2.72) 1-14 
0.073 - 
1.96 (0.67) 1-4 
0.190 - 
  Yes 21 (10.6) 5.24 (2.34) 1-10 1.76 (0.54) 1-3 
Income level (in THB)*          
  None 83 (41.7) 6.67 (2.71) 1-14 
0.149 
 1.92 (0.68) 1-4 
0.086 
 
  <15,000 95 (47.7) 5.95 (2.68) 1-12 - 1.89 (0.64) 1-4 - 
  >15,000 21 (10.6) 5.81 (2.60) 1-10  2.24 (0.54) 1-3  
BMI range
†
          
  Underweight/normal  33 (16.6) 5.27 (2.72) 1-12 
0.073 
 1.79 (0.60) 1-3 
0.133 
 
  Overweight 93 (46.7) 6.35 (2.66) 1-14 - 2.03 (0.68) 1-4 - 
  Obese  73 (36.7) 6.52 (2.67) 1-13  1.89 (0.64) 1-3  
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Table 7.1: Numbers of medications used according to participant characteristics (N=199) (continued) 
 
 
Characteristic N (%) 
Number of all-kind medications Number of DM medications 
Mean (SD) Range 
p-value 
Mean (SD) Range 
p-value 
Univariate Multivariate Univariate Multivariate 
Duration of known DM (years)   
  <5  95 (47.7) 5.49 (2.50) 1-13 
<0.001 0.068 
1.84 (0.64) 1-4 
0.045 0.005 
  >5 104 (52.3)  6.91 (2.70)  1-14  2.03 (0.66) 1-3 
Medical problems (as diagnosed)           
  T2DM only 27 (13.6) 3.22 (1.95) 1-9 
<0.001 
- 1.81 (0.74) 1-4 















       
  T2DM+hypertension     














   THB=Thai Baht; BMI=Body mass index 
   Reference groups in MLR analyses: male (for „gender‟); 18-44 years (for „age‟); unemployed/retired (for „working status‟); <5 years (for 
   „duration of known DM); and T2DM only (for „medical problems‟) 
   * 33.15 THB is approximately equal to 1 USD (data on December 3, 2009). 
    † 
Classified using the Asian BMI cut-offs 
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7.3.1. Extent and patterns of medication use 
The numbers of medications taken by the participants are presented according 
to participant characteristics in Table 7.1. Of 199 participants, polypharmacy was 
documented in nearly three-fourth (n=147, 73.9%). The mean numbers of all-kind 
medications and DM medications were 6.24 (SD=2.70, range 1 to 14) and 1.94 
(SD=0.66, range 1 to 4), respectively. Female gender, older age, unemployment 
status, longer duration of known DM and having hypertension and/or dyslipidemia 
were likely to be associated with higher number of all-kind medications in univariate 
analyses. However, only older age and having hypertension and/or dyslipidemia 
remained significant in MLR analyses. With regards to DM medications, participants 
who were female, aged less than 65 years and had T2DM for at least five years were 
likely to require significantly more medications in both univariate and MLR analyses.  
 
Patterns of DM regimens of the participants are described in Table 7.2. Of 199 
participants, 18.6% required insulin, either as monotherapy or in combination with 
oral hypoglycemic agents (OHAs), and 76.4% required combination therapy for DM. 
In both underweight/normal and overweight/obese groups, the most commonly used 
DM regimen was sulfonylureas plus biguanides (54.5% and 56.0% of participants in 
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     Table 7.2:     Patterns of DM regimens of the participants (N=199) 
 
 
DM regimen N (%) 
Underweight or normal/ 
Overweight or obese 
Type of medication    
   Oral medication only  162 (81.4) 23 (69.7) / 139 (83.7) 
   Insulin (mono-or combined) 37 (18.6) 10 (30.3) / 27 (16.3) 
   
Monotherapy   
    Sulfonylureas                                                                                  20 (10.1) 2 (6.1) / 18 (10.8) 
    Biguanides (Metformin) 11 (5.5) 2 (6.1) / 9 (5.4) 
    Alphaglucosidase inhibitors 1 (0.5) 0 / 1 (0.6) 
    Insulin 15 (7.5) 6 (18.2) / 9 (5.4) 
Total monotherapy  47 (23.6) 10 (30.3) / 37 (22.3) 
   
Combination therapy   
  Two medications   
    Sulfonylureas + Biguanides 111 (55.8) 18 (54.5) / 93 (56.0) 
    Others 8 (4.0) 2 (6.1) / 6 (3.6) 
  More than two medications    
    Sulfonylureas + Biguanides + 




1 (3.0) / 16 (9.6) 
 
    Others 16 (8.0) 2 (6.1) / 14 (8.4) 
Total combination therapy  152 (76.4) 23 (69.7) / 129 (77.7) 
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 For participants with comorbid hypertension (n=153, 76.9%) and/or 
dyslipidemia (n=110, 55.3%), more than 95% of them required medication therapy 
for these comorbidities (Table 7.3). Angiotensin-converting enzyme inhibitors 
(ACEIs) was the most utilized therapeutic class (42.5%) for treating hypertension, 
followed by beta-blockers (BB) (41.2%), thiazide diuretics (37.9%) and calcium 
channel blockers (CCB) (34.6%) while statins was the most utilized therapeutic class 
(79.1%) for treating dyslipidemia. Overall, the most commonly used medications 
among all participants were metformin (81.4%), glibenclamide (67.8%) and 
simvastatin (42.7%) while low-dose aspirin (either 81 or 300 mg) was used in 19.6% 
of the participants (Table 7.4). 
 
7.3.2. Association between polypharmacy and QoL 
No statistically significant association was found between any QoL scores 
(generic present QoL, DM-dependent QoL and AWI scores) and numbers of 
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             Table 7.3:     Treatment of hypertension and dyslipidemia  
 
 




 Lifestyle modification 6 (3.9) 
 Monotherapy 54 (35.3) 
 Combination therapy  
    Two medications 51 (33.3) 
    More than two medications (range: 3 to 6) 42 (27.5) 
Therapeutic class*  
   Angiotensin-converting enzyme inhibitors (ACEI) 65 (42.5) 
   Beta-blockers (BB) 63 (41.2) 
   Thiazide diuretics  58 (37.9) 
   Calcium channel blockers (CCB) 53 (34.6) 
   Angiotensin II receptor blockers (ARB) 26 (17.0) 
   Alpha-1 blockers 10 (6.5) 
   Centrally acting drugs 10 (6.5) 
   Loop diuretics  4 (2.6) 





   Lifestyle modification 1 (0.9) 
   Monotherapy 98 (89.1) 
   Combination therapy (two medications) 11 (10.0) 
Therapeutic class*  
   Statins 87 (79.1) 
   Fibrates (Gemfibrozil) 33 (30.0) 
Total 110 
 
* Some participants received more than one therapeutic class.  
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Table 7.4:     Ten most commonly used medications among the participants  
 
 
No Medication  N  % 
    
1 Metformin 162  81.4 
2 Glibenclamide 135  67.8 
3 Simvastatin 85  42.7 
4 Enalapril 64  32.2 
5 Hydrochlorothiazide  58  29.1 
6 Atenolol 57  28.6 
7 Topical analgesic 45  22.6 
8  Vitamin B1-6-12 41  20.6 
9 Aspirin (81 or 300 mg) 39 19.6 
10 Insulin 37  18.6 
Chapter 7. Polypharmacy and QoL in T2DM                                              Pongmesa, Tipaporn                                                                                
148 










Mean (SD) p-value Mean (SD) p-value Mean (SD) p-value 
       
No. of all-kind medication 






    >5  0.39 (1.21) -1.86 (0.91) -3.71 (2.03) 
       
No. of DM medication 






    >2 0.42 (1.24) -1.86 (0.94) -3.74 (1.99) 
       
Type of DM therapy 






  Insulin (mono- 
or combined)  0.16 (1.12) -1.86 (0.79) -4.21 (1.73) 
       
       
Total 0.40 (1.19)  -1.84 (0.93)  -3.75 (2.03)  
 
AWI=Average weighted impact 
Possible scores: * -3 to +3; 
†
 -3 to +1; 
‡





7.4.1. Extent and patterns of medication use 
Our results showed that polypharmacy was prevalent among our participants. 
Consistent with previous studies,
(146, 150, 151)
 the elderly (aged >65 years) was the 
largest user of all-kind medications in our study. Although this finding was as 
expected, it underlined the importance of an effective medication use strategy to be 
applied in elderly patients as both polypharmacy and older age are found to be 
contributing factors for DRPs and patient non-compliance.
(136, 146)
 Incidentally, even 
though a number of studies found that women were more likely to use more 
medications,
(151, 152)
 a statistically significant association was found only between 
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gender and the number of DM medications but not the number of all-kind 
medications, in this study. Furthermore, it is quite interesting to find that the 
associations of age with the number of all-kind medications and the number of DM 
medications were in opposite direction. This appeared counter-intuitive. However, our 
data showed that participants who were less than 65 years old were more likely to 
have worse glycemic control compared to their older counterparts.  
 
The finding that sulfonylureas plus biguanides was the most commonly 
utilized regimen for DM is unsurprising as these therapeutic classes are recommended 
as first-line medications,
(15)
 and combination therapy with medications from different 
group is often required over time for optimal glycemic control. With regards to 
treatments for DM comorbidities, the finding that ACEI, BB, thiazide diuretics and 
CCB were the most widely utilized antihypertensive agents is consistent with the 
recommendations from the American Diabetes Association (ADA)
(153)
 as well as the 
Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure (JNC 7)
(154) 
that recommend these 
therapeutic classes in patients with DM as they have been found to reduce 
cardiovascular events. Similarly, the use of statins in a majority of participants with 
comorbid dyslipidemia and the use of low-dose aspirin as antiplatelet therapy in a 
number of participants with increased cardiovascular risks are also consistent with the 




7.4.2. Association between polypharmacy and QoL 
Interestingly, although many studies found that polypharmacy could 
negatively affect QoL of patients with DM,
(136, 148, 149)
 this current study did not reveal 
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statistically significant association between polypharmacy and any QoL scores. A 
possible reason may be that the use of polypharmacy could be beneficial for some 
patients in controlling their disease symptoms, so they may not find taking many 
medications to be burdensome.  
 
7.4.3. Study limitations 
We acknowledge several limitations in this study. First, there is a potential for 
recall bias as some participants may not be able to recall all the medications they had 
usually taken during the past three months. Although we try our best to ensure 
completeness of this information by reviewing patient records, it is still possible that 
we may miss some medications that the participants purchased by themselves from 
pharmacies or other sources. Furthermore, some participants might intentionally not 
provide their complete list of medications to avoid being blamed by health 
professionals for taking non-prescribed medications, especially in case of herbal 
medicines. Therefore, the numbers of medications in our study could be under-
reported. Secondly, as this study was conducted in a public hospital, our results may 
have limited generalizability to other groups of patients, settings, and times. Hence, 
our results should be interpreted with cautions and verified in future studies, 
especially among T2DM patients seen in other types of healthcare settings.   
 
7.5. CONCLUSIONS 
Polypharmacy was common among Thai patients with T2DM in this study 
with most patients required combination of oral hypoglycemic therapy. Overall, older 
patients and those with comorbid diseases were likely to require more medications 
while higher number of DM medications was reported among females, those aged less 
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than 65 years and those with T2DM for at least five years. The therapeutic classes of 
medications for treating DM, hypertension and dyslipidemia in our patients are 
generally consistent with major guidelines. However, no significant association was 
revealed between polypharmacy and QoL. 
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Conclusions and Recommendations  
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8.1. CONTRIBUTIONS TO NEW KNOWLEDGE  
The motivation for this thesis was a recognition of the limited information on 
various aspects of T2DM management in Asia, especially in Thailand. Due to the 
known influence of culture on patients‟ perception and outcomes, we realized that 
generalization of the results from studies performed in other countries to patients with 
T2DM in Thailand could be problematic, and hence our decisions to carry out the 
studies as reported in the previous chapters. In this thesis, we have contributed new 
knowledge to the management of DM which may be broadly classified into three 
areas: (1) public knowledge of DM in Thailand; (2) the measurement of health status, 
QoL and treatment satisfaction among patients with DM in Thailand; and (3) 
polypharmacy among patients with T2DM in Thailand. These are briefly summarized 
in the following sections. 
 
8.1.1. Public knowledge of DM in Thailand 
In a cross-sectional survey among the general population in Bangkok (the 
capital and biggest city of the country) and other four central provinces, we found that 
the level of DM knowledge among the Thai public was generally fair according to the 
pre-specified grading criteria derived from our Delphi panel. This highlights that a 
basic level of DM knowledge exists among the Thai population which provides a 
reasonable foundation for further efforts for health promotion and education about 
DM. In addition, we also identified areas of knowledge deficiencies and 
misconceptions that need to be further strengthened or rectified, characteristics of 
people that deserve more attention in DM education, as well as promising channels 
for disseminating information on DM to the Thai public. Interestingly, the people who 
needed more attention in DM education were not the residents in other provinces but 
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the residents of the capital city showing that easier accessibility to health information 
may not necessarily equate to better health knowledge. This observation is further 
supported by the fact that the factors associated with DM knowledge in the two 
groups were not identical. These provide much food for thought for public health 
educators in Thailand when designing future health promotion and education 
programs.   
 
To the best of our knowledge, our study is the first to report on knowledge of 
DM among the general population in Thailand. Hence, it has important implications 
for the design and delivery of tailored public DM education programs to improve 
knowledge of DM among the Thai general population in a cost-effective manner. It 
may also assist health educators in formulating health promotion and education 
materials that are geared to meeting needs of Thai people in different areas. 
Additionally, it may serve as a useful reference for other Asian countries of similar 
developmental status.  
 
8.1.2. The measurement of health status, QoL and treatment satisfaction among 
patients with DM in Thailand 
Although the assessment of PROs such as health status, QoL and treatment 
satisfaction is now regarded as an important part of DM management, there are 
several barriers to the routine assessment of PROs in Thailand. The most important of 
which is the lack of culturally valid assessment tools, which then leads to a paucity of 
data. To address this deficiency, we sought first to establish the appropriate 
assessment tools and next to report data of the application of these assessment tools. 
In Chapter 4, we developed and validated a Thai version of a well-recognized DM-
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specific QoL instrument, namely the Audit of Diabetes-Dependent Quality of Life 
(ADDQoL-19) in a sample of DM patients. After rigorous steps in linguistic 
validation process, the instrument was shown to be semantically, conceptually and 
operationally equivalent to its original UK English version. Both health professionals 
and DM patients who participated in the linguistic validation process agreed that all 
19 domains included in this questionnaire are important and relevant to Thai patients 
with DM in general. In psychometric tests, individualization (i.e. weighting impact 
ratings by importance and the availability of a N/A option) which is the unique 
characteristic of the ADDQoL-19 was proven to be useful and important for a more 
accurate assessment of the patients‟ QoL. The Thai ADDQoL-19 also demonstrated 
very good internal consistency. However, its factor structure, particularly the item 
„sexual relationship,‟ and its known-group validity may require further investigations 
highlighting the importance of cross-cultural adaptation of any PRO instruments. 
Overall, our Thai ADDQoL-19 is deemed to be a promising tool for assessing QoL of 
patients with T2DM in Thailand. However, due to time and resource constraint, its 
relevance in T1DM and gestational DM remains to be studied. 
 
In Chapter 5, we evaluated the psychometric properties of a recently 
developed Thai version of a DM-specific treatment satisfaction instrument, namely 
the Diabetes Treatment Satisfaction Questionnaire status version (DTSQs). Based on 
our findings, more evidence on the psychometric properties of the Thai DTSQs is 
warranted as it demonstrated only moderate internal consistency, and its 
unidimensionality in this population could not be confirmed. There was also limited 
evidence to support the known-groups validity of the DTSQs in the Thai population. 
We have suggested that further improvement to the Thai DTSQs may be made by 
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revising the items „understanding on DM‟ and „recommendation to others,‟ as they 
were found to load on a different factor from other Treatment Satisfaction items. This 
chapter clearly highlights the need for cross-cultural adaptation of PRO instruments. 
 
In Chapter 6, as a logical next step, we reported the results of using these 
instruments in patients with DM in Thailand. Interestingly, we found that DM had 
little effect on the patients‟ perceived health status, with „pain/discomfort‟ being the 
most commonly reported problem and „self-care‟ being the least affected one. Even 
though the majority of patients reported „good‟ or „neither good nor bad‟ for their 
general present QoL, they all agreed that their QoL would be better if they did not 
have DM. Moreover, the patients reported a substantial negative impact of DM on 
their QoL, particularly on „self-confidence,‟ „working life‟ and „living conditions‟ 
while „people‟s reaction‟ was found to be the domain of life least affected by DM. We 
also identified „financial situation,‟ „working life‟ and „family life‟ to be the three 
most important domains of life of the patients while the least importance was given to 
„sexual relationship‟ and „freedom to drink‟ reflecting the influence of culture on 
subjects‟ choices. Based on our findings, it could be implied that the impact of DM on 
the patients would be underestimated if the EuroqoL-5D (EQ-5D) was used as a 
single instrument in this study, thus further underlining the necessity of using a DM-
specific instrument for a more comprehensive assessment of PROs. Regarding 
treatment satisfaction, we find high level of satisfaction with DM treatment for the 
majority of our patients, particularly the satisfaction with current treatment in general. 
This is quite encouraging as patients who are satisfied with their treatment tend to 
have better medication adherence. However, the ceiling effect of the satisfaction score 
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observed in our study indicates the need for using the DTSQ change version (DTSQc) 
together with the DTSQs in a study assessing changes in treatment satisfaction.  
 
Additionally, we identified factors potentially associated with health status, 
QoL and treatment satisfaction in Thai patients with DM. We found that lower 
income level was likely to affect health status negatively while lower education level 
and unemployment status could adversely affect QoL, and female gender and older 
age were associated with higher treatment satisfaction. It is noteworthy that no 
significant association was revealed between any PROs and other demographic and 
clinical characteristics of the patients, including obesity, marital status, duration of 
known DM, presence of DM complications/comorbidities and type of DM therapy. 
Further studies would be needed to confirm these findings. 
 
We were the first to translate and cross culturally adapt a Thai version of the 
ADDQoL-19 which serves as the first DM-specific QoL instrument available in the 
Thai language. The Thai version of the DTSQs was previously developed by other 
researchers. However, we are the first to provide detailed information on the 
psychometric properties of the Thai versions of both the ADDQoL-19 and the 
DTSQs. Hence, this would pave the way for future assessment of DM-specific QoL 
and treatment satisfaction among patients with DM in Thailand. It also sheds some 
lights on the potential challenges of translating and culturally adapting PRO 
instruments from Western origin to Asian clinical settings. The findings from our 
psychometric tests may be useful for an improvement of the instruments‟ properties in 
the future. Furthermore, our findings on PRO assessment in Thai patients with DM 
would provide useful insights on the impact of DM and its treatment on health status 
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and QoL of the patients, including the patients‟ preference of therapy as well as the 
factors associated these outcomes. The information may be useful to facilitate health 
professional-patient communication and health professionals‟ decision of a treatment 
option, thus possibly contributing to treatment success in patients with DM.  
 
8.1.3. Polypharmacy in patients with T2DM in Thailand 
In Chapter 7, we reported the patterns and prevalence of polypharmacy (i.e. 
the concurrent use of five or more different medications) among T2DM patients seen 
at a tertiary hospital in central Thailand and evaluated the association between 
polypharmacy and QoL. The prevalence of polypharmacy was estimated to be 74% 
among our study participants. As expected, a significantly higher number of all-kind 
medications was reported by older patients and those with comorbidities, i.e. 
hypertension and/or dyslipidemia. However, female patients, those aged less than 65 
years and those with long duration of DM (five years and over) were found to be the 
groups requiring more medications for treating T2DM. In general, the use of 
medications for treating T2DM as well as its comorbidities in our patients was 
consistent with standard guidelines. Interestingly, no significant association was 
observed between polypharmacy and QoL.  
 
We were the first to report the prevalence of polypharmacy and the lack of 
association between polypharmacy and QoL among Thai patients with T2DM. The 
findings may be useful for health professionals in planning effective medication use 
strategies for this group of patients, thus possibly enhancing the quality of T2DM care 
and improving patients‟ outcomes.  
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8.2. MAIN LIMITATIONS  
 The limitations of each study have been discussed in details in the individual 
chapters; therefore, only the two main limitations are emphasized here. The first one 
which could be applied to the studies on DM knowledge is the potential sampling bias 
that lies in the convenience sampling method used in recruiting study participants. 
Due to the time and resource constraints, we were unable to perform a true population 
sampling. Therefore, we would recommend that our studies should be served as pilot 
studies for a more comprehensive investigation of DM knowledge among the Thai 
population in the future. The second limitation is that our study population was 
restricted to only those in the central region of Thailand. Therefore, some cautions are 
needed when generalizing our findings to the population in other regions of the 
country.  
 
8.3.      RECOMMENDATIONS FOR FUTURE STUDIES 
Based on the limitations and findings obtained from each study, this thesis 
raises some concerns as well as interesting issues that should be further addressed/ 
investigated in future studies as follows:  
 
 Due to the limitations of the convenience sampling method that we adopted in 
the studies on DM knowledge, we would propose future studies to employ a random 
sampling strategy although we envisage that this is going to be a very challenging 
undertaking. 
 
 As the current thesis focuses on people in the central region, future studies on 
similar issues should consider including other core populations of Thailand, i.e. the 
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Northern Thais, Northeastern Thais and Southern Thais, to verify the robustness of 
our results. It may be interesting as well to explore whether any difference exists 
between the outcomes from people in the central and those in other regions of the 
country.  
 
 Further studies are warranted to provide more evidence on factor structures, 
reliability and known-groups validity of the Thai ADDQoL-19 and DTSQs. In 
addition, an evaluation of other psychometric properties that have not been addressed 
in our studies, i.e. sensitivity to change over time and test-retest reliability, could be 
explored by studies using a longitudinal study design.   
 
 Our findings suggest the necessity of using the DTSQc to overcome ceiling 
effects in a follow-up study evaluating satisfaction changes in patients with DM. As 
information on psychometric properties of this instrument is currently unavailable, 
future studies are necessary to address this issue.  
 
 The lack of association between polypharmacy and QoL in our study is 
surprising and warrants further studies, possibly in larger population. 
 
 It may be interesting to determine if there is any difference between PROs of 
patients with DM seen in different types of healthcare settings. Therefore, similar 
studies may be conducted in private hospitals and further compare the results to our 
findings.  
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Future studies addressing the above-mentioned issues would complement and 
confirm the findings from the current thesis, and provide valuable information on 
various approaches in management of T2DM in Thailand and contribute to the better 
and more holistic management of this impending endemic.  
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